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Abstract  
Atherosclerosis is a progressive disease characterized by the appearance of inflamed lesions 
in the arterial wall. The main component of an atherosclerotic lesion is a cholesterol-filled 
macrophage (a foam cell). In addition, the inflamed intima contains numerous mast cells 
which, upon activation, acutely secrete serine proteases and other mediators that can 
influence the progression of atherosclerotic lesions. HDL-mediated removal of cholesterol 
from the lipid-filled macrophages and its transfer to the liver and feces, a process termed 
macrophage- reverse cholesterol transport (m-RCT), is an important anti-atherogenic 
mechanism. The multi-step m-RCT pathway appears to be modulated at the various steps. 
Mast cell-derived proteases, by degrading HDL lipoproteins, may affect the early steps of m-
RCT, a possibility that has not been investigated in vivo. Psychological stress, an established 
risk factor for cardiovascular diseases and a potent activator of mast cells, might also 
interfere with m-RCT. With an aim to answer the question whether cholesterol flux through 
the m-RCT pathway could be physiologically modulated by mast cell activation and stress, 
this thesis assessed the functionality of the various components of the m-RCT pathway 
using the mouse as the experimental model. In the first study, a short-term m-RCT in vivo 
analysis was validated and performed to investigate the consequence of local mast cell 
activation for the functionality of HDL in m-RCT. The following study utilized the same 
method to address the effects of acute psychological stress on m-RCT. In the third study, 
the effects of stress on m-RCT were assessed in a chronic setting. An inhibitory role of 
peritoneal mast cell activation in vivo on the initial step of the m-RCT was established. 
Conversely, stress exposure, both acute and repetitive, induced multiple m-RCT-promoting 
responses in the liver and intestine. Mice exposed to acute psychophysical stress exhibited 
accelerated m-RCT due to compromised intestinal absorption of cholesterol, uncovering a 
novel functional connection between the stress hormone corticosterone and m-RCT. 
Repeated exposure to the same stressor resulted in increased fecal excretion of bile acids 
which also stimulated the rate of m-RCT. Altogether, the results presented in this thesis 
demonstrate that the m-RCT pathway is effectively modulated by two physiological factors, 
psychological stress and mast cell activation, which are involved in the pathology of 
atherosclerosis. 
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I Introduction 
Cholesterol is an essential structural component of the cell membrane and a precursor of 
biologically active compounds such as steroid hormones, bile acids, and vitamin D. The 
synthesis, transport, and excretion of cholesterol are tightly controlled both at the cellular 
and whole-body level. Malfunction of the regulatory mechanisms may result in deleterious 
effects for the organism as a whole. Deposition of cholesteryl ester -filled macrophages in 
the arterial intima is a characteristic feature of atherosclerosis, the clinical manifestations of 
which afflict more than half of the population globally. Currently, atherosclerosis underlies 
the two global leading causes of death, coronary artery disease and stroke (World Health 
Organization, 2012). Risk factors for atherosclerosis include adverse blood lipid profile, 
diabetes, metabolic syndrome, hypertension, smoking, and psychological stress. The 
multiplicity of risk factors reflects the multi-factorial nature of the disease. Cholesterol-
transporting lipoproteins play a key role in the atherosclerotic disease process, and low 
levels of high-density lipoprotein (HDL)-cholesterol constitute an important risk factor for 
cardiovascular disease  (Di Angelantonio et al. 2009). One of the major anti-atherogenic 
functions of HDL is to promote the reverse cholesterol transport (RCT), a process in which 
HDL particles carry excess cholesterol from peripheral tissues and cholesterol-filled 
macrophages present in the arterial wall back to the liver and intestine for fecal excretion.  
A myriad of genetic and environmental factors contribute to the regulation of the multi-
step RCT pathway. Mast cells are bone marrow-derived inflammatory cells that are found in 
atherosclerotic lesions. Their functional significance in the development of atherosclerotic 
lesions appears to involve the production and release of various cytokines, chemokines, and 
proteases (Bot and Biessen 2011). Psychological stress is also considered an independent 
risk factor for atherosclerosis (Kivimäki et al. 2012). By increasing sympathoadrenal activity, 
stress challenges energy metabolism and the cardiovascular system. Whether psychological 
stress or mast cell activation affects the functionality of the RCT pathway and through that, 
the risk of atherosclerosis, is not known. In this thesis, several mouse models are applied to 
study the effects of mast cell activation and psychological stress on macrophage-specific 
RCT. The aim is to provide novel information on the regulation of the RCT process which 
could help understand better the conditions that lead to the development of 
atherosclerosis. 
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II Review of the literature 
1. Atherosclerosis and lipoproteins 
The concept of atherosclerosis as a cholesterol-driven pathology of the arteries was 
introduced already in the beginning of the 20th century (Anitschkow and Chalatow 1983). 
Pathophysiological events leading to atherosclerotic lesion formation begin early in life and 
take place in the intima, the inner layer of the arterial wall (Stary 1990). Circulating 
lipoproteins, the carriers of cholesterol, lie at the heart of the process. Figure 1 describes 
the classification of the key lipoproteins present in human plasma.  
 
  Chylomicron      VLDL       LDL        HDL 
Size (diameter, nm)     75-1200      30-80     18-25        8-12 
Sources     Intestine      Liver Liver (VLDL) Intestine, liver 
Average blood level (mM)*      varied    0.1 - 0.7    2.6 - 3.9    1.3 - 2.0 
Half-life in blood (hours)         0.5     0.5 - 1     48 - 96    96 - 120 
Major apolipoproteins   apoC, B, E   apoC, B, E     apoB  apoA-I, A-II 
Atherogenicity (- /+/++)           -          +        ++          - 
 
Figure 1. The structure and classification of the main classes of lipoproteins found in blood. All 
lipoproteins consist of a surface layer build from phospholipids (PL), unesterified cholesterol (CHOL), 
and apolipoproteins, and a core containing triglycerides (TG) and esterified CHOL. The average 
contribution (% of dry weight) of each component in different lipoproteins is shown. Chylomicrons are 
the main carriers or dietary lipids, whereas lipids and CHOL present in VLDL (very low-density 
lipoproteins) are derived from the liver. TG-depleted VLDL form, via classes of intermediate density 
lipoproteins, CHOL-rich LDL particles (low-density lipoproteins), which are the most atherogenic class 
of lipoproteins. Also circulating HDL (high-density lipoproteins) carry significant amount of CHOL, but 
they are anti-atherogenic. The chylomicrons, VLDL, and LDL all contain apolipoproteins that belong to 
class B (apoB), whereas HDL do not. *Values vary depending on age, sex, and lifestyle; the average 
levels in a healthy population are from Langsted et al. 2008. 
 
In areas especially susceptible to lesion development, local blood flow patterns create 
mechanical stresses that cause adaptive thickening of the intima and promote the 
infiltration of plasma components, such as lipoprotein particles, through the endothelium 
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into the vessel wall (Mehrabian et al. 1991). Both HDL and LDL particles are small enough to 
penetrate the healthy intact endothelial cell layer of the arterial wall in a concentration-
dependent fashion. The smaller HDL particles efficiently enter and exit the intimal layer, 
whereas the larger LDL particles are more easily trapped in the proteoglycan-rich 
extracellular matrix of the intima (Nordestgaard et al. 1990, Nievelstein et al. 1991). A 
circulating lipoprotein pattern characterized by elevated LDL-cholesterol and VLDL-
triglyceride, and reduced HDL-cholesterol levels favors cholesterol accumulation into the 
arterial wall and is thus termed atherogenic dyslipidemia (Stamler et al. 1986).  
LDL-cholesterol accumulated into the intima can be cleared by macrophages, immune cells 
that specialize in scavenging lipids and debris from their surroundings. Normally, cellular 
cholesterol level is kept under tight negative feedback control, but in macrophages and 
some types of vascular smooth muscle cells expressing scavenger receptors, large amounts 
of intracellular cholesterol may accumulate (Figure 2). Oxidation, proteolysis, and lipolysis 
of the LDL particles that have been trapped in the intima stimulate the lipid scavenging 
activity which eventually transforms macrophages into lipid-filled foam cells (Haberland et 
al. 1988, Ylä-Herttuala et al. 1989). The first fatty streaks, the early atherosclerotic lesions 
containing aggregates of lipid-filled foam cells, appear in the arteries already during the first 
decade of human life (Stary 1990). Gradually, the accumulation of lipids and macrophages 
into the intima evokes a local inflammatory response: the arterial endothelium is activated, 
and the expression of pro-inflammatory cytokines and cell adhesion molecules, such as 
monocyte chemotactic protein 1 (MCP-1), intercellular adhesion molecule 1 (ICAM-1), 
vascular cell adhesion molecule 1 (VCAM-1), and endothelial selectin, is increased (Li et al. 
1993, Zeuke et al. 2002). These molecules attract and arrest macrophage precursor cells 
(monocytes) and lymphocytes into the arterial intima, fueling a vicious cycle of cell 
recruitment and lipid deposition (Smith et al. 1995, Collins et al. 2000) (Figure 2). An 
advanced atherosclerotic lesion comprises a necrotic lipid core built from extracellular 
lipids, crystallized cholesterol, cellular debris, foam cells, mast cells, and smooth muscle 
cells. The core is buried under a fibrous cap that can be thin and fragile, or thick and stable 
(Guyton and Klemp 1989). At late stages of the disease, coronary atherosclerotic lesions 
may severely limit blood supply which induces myocardial ischemia. Alternatively, a lesion 
with unstable fibrous cap may erode and rupture (Mäyränpää et al. 2006), which triggers 
thrombosis that may lead to a stroke or sudden cardiac death. 
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Figure 2: A schematic overview of an early stage atherosclerotic lesion in the arterial wall. The 
arterial intima is lined with a luminal endothelial cell layer and with an elastic lamina that borders the 
smooth muscle cell -containing arterial middle layer, the media. The small LDL particles cross the 
endothelium and are retained within the intimal proteoglycans (not shown). Modification and 
aggregation of LDL particles in the intima marks them as substrates to macrophage scavenger 
receptors (mainly scavenger receptor A; SR-A, and cluster of differentiation 36; CD36). Uncontrolled 
uptake of LDL (cholesterol influx) results in the formation of cholesterol-filled macrophage foam cells. 
Circulating inflammatory cells (such as monocytes) bind to adhesion molecules presented by activated 
endothelial cells, and move into the intima. Cytokines produced by the inflammatory and endothelial 
cells also attract mast cells and medial smooth muscle cells into the intima. ApoA-I-containing HDL 
particles are able to hinder intimal lipid accumulation by inducing cholesterol release (cholesterol 
efflux) from foam cells via the ATP-binding cassette (ABC) transporters A1 and G1 (ABCA1, ABCG1). 
References are presented in the main text. 
 
2. The structure and functions of HDL  
HDL is a heterogeneous mixture of lipoprotein particles that constitute the densest (1,063-
1,210 g/ml) and the smallest (7-12 nm) lipoprotein fraction in circulation (Rothblat and 
Phillips, 2010). The two key subtypes of HDL; the mature, spherical particles and the 
immature, small, disk-shaped particles that are named α-HDL and preβ-HDL, respectively, 
based on their mobility on an electrophoresis gel, possess functionally refined roles in 
cardiovascular physiology. 
2.1 Structure of apoA-I and HDL 
The major protein component of HDL, apoA-I, is mostly synthetized by hepatocytes and 
enterocytes. The human apoA-I is a 243-amino acid protein made up of repeating 
amphipathic α-helixes. The protein contains two key domains, an N-terminal α-helix bundle 
and a separately folded C-terminal domain: In human apoA-I, the C-terminal domain is 
more hydrophobic and has higher lipid affinity than the N-terminus (Alexander et al. 2011). 
Mouse apoA-I shares only 65% amino acid sequence identity with human ApoA-I. Yet, their 
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secondary and tertiary protein structures are very similar, although the N-terminal domain 
of mouse apoA-I has higher lipid affinity when compared to human apoA-I (Tanaka et al. 
2008).  
The majority of circulating apoA-I is bound to the mature -HDL particles and only a minor 
fraction exists in the small disk-shaped preβ-HDL particles. The repeating amphipathic α-
helixes of apoA-I reversibly bind them to the surface of HDL (Segrest et al. 1992). This 
stabilizes the structure of the lipoprotein particles. In each preβ-HDL particle, two to four 
apoA-I molecules sit in a discoidal lipid monolayer comprised of phospholipids and a small 
amount of cholesterol (Ishida et al. 1987, Segrest et al. 1999). While circulating throughout 
the body, the particles mature from discoidal to spherical by acquiring cholesterol from 
cells expressing the cholesterol transporters ABCA1 and ABCG1, and phospholipids, 
triglycerides, and apolipoproteins from other circulating lipoprotein particles (Rothblat and 
Phillips, 2010). The fully mature, spherical α-HDL particles consist of ~50% protein (apoA-I, 
apoA-II, apoE, and apoCs), ~20% cholesterol (as fatty acid-esters in the core and free 
cholesterol on the surface), ~5-8% core triglycerides, and ~22-25% surface layer 
phospholipids (Figure 1).  
Structural alteration of HDL and modification of its components may drastically alter the 
functional properties of the lipoprotein particle (Brown et al. 2010, Tan et al. 2014). The 
lipoprotein-associated phospholipid transfer protein (PLTP) transfers phospholipids from 
various sources to HDL, which increases the size of HDL particles. During this process, small 
apoA-I-containing particles shed from the surface of the enlarged HDL, which is thought to 
be an important mechanism for preβ-HDL formation (Lie et al. 2001). The nascent, poorly 
lipidated preβ-HDL particles avidly acquire more cholesterol from peripheral tissues 
(Rothblat and Phillips, 2010). Cell membrane-bound endothelial and hepatic lipases (EL and 
HL) are examples of HDL-modifying enzymes that, by removing phospholipids and 
triglycerides, decrease the average size of circulating HDL (Brown et al. 2010).  
In addition to the size of the circulating HDL particles, individual lipid and protein 
components of the particles are subject to modification by several mechanisms including 
oxidation (Nagano et al. 1991), glycation (Duell et al. 1991), and proteolysis (Kunitake et al. 
1990). These modifications typically occur within tissues and are induced by various cell 
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types. A prime example of a cell that is capable of excreting HDL-modifying proteolytic 
enzymes is the mast cell, the functions of which are introduced in Section 4.  
2.2 Cardioprotective functions of HDL 
The anti-atherogenic potential of HDL can be explained by its various cardioprotective 
functions in the body. The various molecules carried by mature HDL particles inhibit 
vascular inflammation, thrombosis and the oxidative modifications of LDL (Navab et al. 
2000), and promote endothelial cell function and angiogenesis (Rye and Barter 2014). The 
key cardioprotective feature of HDL is ascribed to its capacity to transport cholesterol from 
peripheral tissues towards the liver for subsequent elimination via feces, a concept 
introduced almost 50 years ago (Glomset 1968). This reverse cholesterol transport (RCT) 
process is referred to as macrophage-specific RCT (m-RCT) when the cholesterol donor cell 
is a cholesteryl ester-filled macrophage. Removal of cholesterol from macrophage foam 
cells by apoA-I and HDL particles markedly reduces cholesterol accumulation and 
inflammatory burden in the vascular wall, hindering the growth of atherosclerotic lesions 
(Hara and Yokoyama 1991, Xie et al. 2009, Potteaux et al. 2011). 
3. The reverse cholesterol transport pathway 
RCT comprises several consecutive steps: HDL-mediated removal of cholesterol from 
peripheral tissues, its subsequent transport to the liver, and ultimate excretion in feces. 
Although cholesterol derived from macrophages makes only a minor contribution to the 
total mass of cholesterol excreted in feces, it is vital for the maintenance of cholesterol 
balance in the arterial intima (Cuchel and Rader 2006, Xie et al. 2009). The following 
chapters introduce the key steps of the m-RCT pathway and describe the main molecular 
mechanisms and mediators governing their regulation. 
3.1 Cholesterol efflux from macrophages 
Efflux of cholesterol from macrophage foam cells to HDL through membrane-bound 
cholesterol transporter proteins is considered as the first step of m-RCT (Table 1). The 
proposed mechanisms for the transfer of intracellular cholesterol to HDL include: 1) ABCA1-
mediated active, unidirectional cholesterol efflux to lipid-free or lipid-poor apoA-I (Bodzioch 
et al. 1999, Alexander et al. 2011); 2) ABCG1-mediated active, unidirectional cholesterol 
efflux to spherical HDL  (Wang et al. 2004); 3) scavenger receptor class B member 1 (SR-BI) -
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mediated passive, bidirectional transfer to mature HDL  (Ji et al. 1997), and; 4) passive 
aqueous diffusion, facilitated by the phospholipid-rich surface of HDL.  
Cholesterol efflux through ABCA1 is well-characterized and is thought to predominate in 
most tissues, whereas the relative importance of the other mechanisms for cholesterol 
efflux in vivo is less clear. ABCA1 is expressed ubiquitously, and its function, especially in the 
hepatic and intestinal cells which produce apoA-I, is vital for the formation of functional 
HDL particles (Alexander et al. 2011). At the molecular level, it is known that cholesterol 
efflux through ABCA1 involves binding of apoA-I to ABCA1, which triggers phospholipid 
translocation to the outer leaflet of the cellular plasma membrane. This induces the 
formation of exovesiculated lipid domains which promote the transfer of cholesterol from 
the cell membrane to apoA-I (Vedhachalam et al. 2007). The hydrophobic C-terminus of 
human apoA-I is especially crucial for this process (Tanaka et al. 2008).  
Table 1. Major steps of m-RCT and the key cell types and transporter proteins involved 
Step of m-RCT Site/cell type Transporter proteins (ligand / function) 
Cholesterol efflux  
to HDL 
Arterial wall/ 
macrophage  
foam cell 
ABCA1 (cholesterol to apoA-I and apoE) 
ABCG1 (cholesterol to HDL) 
SR-BI (cholesterol to and from HDL) 
Cholesterol and  
bile acid uptake  
by the liver  
Sinusoidal  
hepatocyte 
SR-BI  (cholesterol from HDL)  
LDL-receptors (apoB-containing lipoproteins)  
Canalicular 
hepatocyte 
NTCP (sodium-dependent, major bile acid uptake) 
OATPs (sodium-independent, minor bile acid uptake) 
Biliary secretion 
of cholesterol 
and bile acids  
into intestine 
Sinusoidal & 
canalicular 
hepatocyte  
ABCG5/G8 (cholesterol transfer into bile) 
MDR2 (phospholipid transfer into bile) 
NPC1L1 (cholesterol reuptake from bile*) 
Sinusoidal  
hepatocyte & 
cholangiocyte 
BSEP (major bile acid species into bile) 
MRP2, MDR1 (rare bile acids into bile) 
ASBT (cholangiocytes: bile acids into circulation) 
OSTα/β (cholangiocytes: bile acids into circulation) 
Intestinal re-
absorption of 
cholesterol and  
bile acids 
Duodenal  
enterocyte 
NPC1L1 (cholesterol absorption from intestinal lumen) 
ABCG5/8 (cholesterol transfer to intestinal lumen)  
Ileal enterocyte  
& colonocyte 
ASBT (apical, bile acid absorption from intestinal lumen) 
ILBP (cytoplasm, bile acid transport to the basolateral border) 
OSTα/β (basolateral, bile acid transfer into circulation) 
MRP2 (apical, minor bile acid transfer to intestinal lumen) 
MRP3 (basolateral, minor bile acid transfer into circulation) 
* Mice do not express hepatic NPC1L1 (Tang et al. 2011). Other references can be found in the main 
text. The mRNA expression of bolded transporters was studied in this thesis. 
 
Once cholesterol has been effluxed to HDL, it is esterified to a fatty acid by the HDL-bound 
enzyme lecithin-cholesterol acyltransferase (LCAT). The activity of LCAT is stimulated by the 
apoA-I present on the HDL particle surface (Wu et al. 2007). Esterification increases the 
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hydrophobicity of cholesterol, and cholesteryl esters move to the core of the lipoprotein 
particle allowing HDL to mature by accepting more cholesterol through the cell membrane 
transporters  (Glomset 1968). LCAT deficiency leads to impairment of this process and, 
consequently, in very low circulating levels of HDL. However, only a minor reduction in m-
RCT has been observed in LCAT-deficient rodents (Tanigawa et al. 2009).  
From HDL, cholesteryl esters can be transferred, in exchange to triglycerides and, to a lesser 
extent, phospholipids, to other plasma lipoproteins. An enzyme facilitating this process is 
named the cholesteryl ester transfer protein (CETP) (Barter et al. 1982). The activity of CETP 
decreases the amount of cholesterol in HDL, and promotes the formation of triglyceride-
rich HDL particles. The triglyceride-rich HDL particles are prone to lipolysis by the HL and are 
cleared rapidly from the circulation (Rashid et al. 2003). In humans, CETP transfers 
cholesterol from HDL to apoB-containing LDL and triglyceride-rich VLDL particles. 
Cholesterol transferred to the LDL and VLDL particles can be taken up into the liver via the 
hepatic LDL-receptors (Brown et al. 1981). In mice and other species not expressing CETP, 
the majority of circulating cholesterol resides in HDL particles, from where it is effectively 
sequestered by the hepatic SR-BI (Acton et al. 1996) (Table 1).  
3.2 The hepatic bile acid synthesis 
In the liver, cholesterol derived from circulating lipoproteins is mixed with that from 
endogenous synthesis. The hepatic de novo cholesterol synthesis is mainly regulated by the 
transcription factor sterol regulatory element-binding protein 2 (SREBP2), which accurately 
senses cellular cholesterol levels and adjusts the rate of hepatic cholesterol synthesis and 
uptake accordingly (Sharpe and Brown 2013). Cholesterol cannot be stored in the liver in 
large quantities, therefore it is disposed of by delivering it into the circulation in VLDL 
particles (to provide cholesterol to peripheral tissues) or by excreting it into bile as such or 
in the form of bile acids.  
Bile acids are a heterogeneous group of acidic molecules built on the steroid backbone of 
cholesterol. The enzymatic conversion of cholesterol into bile acids occurs through several 
pathways that employ members of the cytochrome P450 family of metabolic enzymes. A 
classic/neutral hepatic pathway accounts for 80-90% of bile acid synthesis in man under 
normal physiological conditions (Pullinger et al. 2002). An alternative/acidic pathway, 
utilized also by extrahepatic cells, produces most of the remaining (in rodents up to 25%) 
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bile acids (Schwarz et al. 2001, Rosen et al. 1998). Cholesterol 7α-hydroxylase (CYP7A1) is 
the rate-limiting enzyme of the neutral pathway, whereas cholesterol 27α-hydroxylase 
(CYP27A1) is the first enzyme on the acidic pathway. The neutral bile acid synthetic 
pathway consists of 16 enzymatic steps that lead to the formation of two primary bile acids, 
cholic acid and chenodeoxycholic acid. Activity of the enzyme sterol 12α-hydroxylase 
(CYP8B1) determines the ratio of the formed end products. The acidic pathway produces 
mainly chenodeoxycholic acid, and it supports bile acid synthesis especially if the neutral 
pathway is not functioning properly (Schwarz et al. 2001, Pullinger et al. 2002). All bile acids 
are amphipathic, which accomplishes their role as absorption enhancers of a variety of 
lipid-soluble substances in the gut. Most of the newly synthesized bile acids are conjugated 
to glycine or taurine in the liver and will later be modified by gut microbiota (Ridlon et al. 
2006), resulting in the formation of several different species of secondary bile acids with 
distinct properties and biological activities.  
3.3 Cholesterol and bile acid transport into the intestine 
Bile consists of mixed micelles build from bile acids, cholesterol and phospholipids, and a 
small amount of bilirubin. The secretion of the various components of bile is largely 
mediated by hepatic molecules that belong to the family of ABC-transporters (Table 1). 
Unesterified cholesterol is secreted into the hepatic canaliculus by the ABCG5/G8 (Yu et al. 
2002, Dikkers et al. 2013), while phospholipids, essential for cholesterol solubilization in the 
bile, are transported by the phosphatidylcholine flippase (also known as multidrug 
resistance 2, MDR2) (Smit et al. 1993) (Figure 3). Bile acids are secreted into the canaliculus 
by the apical bile salt export pump (BSEP), which transports monovalent tauro- and 
glycoconjugated bile acids (Byrne et al. 2002, Henkel et al. 2013), and by the multidrug 
resistance-associated protein 2 (MRP2) and multidrug export pump 1a (and MDR1a), which 
transport divalent (sulphated or glucuronidated) bile acids (Lam et al. 2005). Bile is stored 
and concentrated in the gallbladder which empties its contents through the biliary duct into 
the duodenum in response to cholecystokinin released upon meal ingestion (Hepner 1975).  
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Figure 3. The enterohepatic cycle of cholesterol and bile acids in mice. Cholesterol (CHOL) carried by 
HDL is taken up from the sinusoidal blood via the hepatic scavenger receptor B1 (SR-BI). Depending on 
the levels of bile acids (sensed by the farnesoid x-receptor, FXR) and CHOL in the hepatocytes, CHOL 
may be transformed into bile acids (red dots) by a multi-step pathway involving several hepatic 
cytochrome P450 enzymes (CYP7A1, CYP8B1 and CYP27A1), or it may be secreted as such into the 
biliary canaliculus. The bile salt export pump (BSEP), multidrug resistance-associated protein 2 
(MRP2), and multidrug export pump 1a (MDR1a) transport bile acids into bile, while phospholipids 
(PL) and CHOL are transported to the biliary canaliculus by the multidrug resistance 2 (MDR2) and the 
ATP-binding cassette transporter G5/G8 heterodimer (ABCG5/G8), respectively. Apically expressed 
SR-BI may also contribute to biliary CHOL transport (Dikkers et al. 2013). Both CHOL and bile acids 
enter the common bile duct, which empties into the duodenum. From biliary CHOL-PL micelles, a 
fraction of CHOL is absorbed into enterocytes through the Niemann-Pick type C1-like 1 protein 
(NPC1L1) to be returned to the circulation as a constituent of chylomicrons and VLDL, while the rest is 
lost in feces. Compared to cholesterol, bile acids are subject to more efficient enterohepatic 
circulation. They are reclaimed into the enterocytes by the apical sodium-dependent bile salt 
transporter (ASBT) and transported by the ileal bile acid binding protein (ILBP) to the basolateral 
membrane, where they are transported to the portal circulation by the heterodimeric organic solute 
transporter (OSTα/β), and to a lesser extent, by the multidrug export pump 3 (MRP3). Circulating bile 
acid levels are kept low by hepatic bile acid re-sequesterization through the Na
+
-taurocholate 
cotransporting polypeptide (NTCP) and the organic anion-transporting polypeptides (OATPs). If not re-
excreted in bile, excess hepatic bile acids may also be directed back into circulation via basolateral 
MRP3. References are presented in the main text. 
 19 
 
In the duodenum, the constituents of bile are mixed with dietary cholesterol and lipids to 
form large micelles. Approximately 95% of bile acids and ~25-75% of cholesterol (Sehayek 
2003) are reabsorbed from these micelles when they pass through the small intestine. The 
almost complete reclamation of bile acids into ileal enterocytes is accomplished by the 
active cooperation of three molecules (Figure 3): the apical sodium-bile acid cotransporter 
(ASBT) (Shneider et al. 1995), the cytoplasmic ileal bile acid binding protein (ILBP) (Lin et al. 
1990), and the basolateral heteromeric organic solute transporter (OSTα-OSTβ) (Dawson et 
al. 2005, Rao et al. 2008). To facilitate the absorption of secondary bile acids synthesized by 
colon-resident bacteria, low amounts of ASBT and OSTα-OSTβ are expressed also in the 
colon (Dekaney et al. 2008), although in general, passive absorption predominates in the 
large intestine.  
The Niemann-Pick type C1-like 1 protein (NPC1L1) in the apical membrane of the duodenal 
and jejunal enterocytes is responsible for active cholesterol absorption (Xie et al. 2013). 
Binding of cholesterol to NPC1L1 on the cell membrane facilitates the formation of 
cholesterol microdomains that are internalized into cells through clathrin-mediated 
endocytosis. The number of NPC1L1 proteins that are retained on the apical cell membrane 
is controlled through endocytic recycling of the transporter (Skov et al. 2011). The apical 
border of enterocytes hosts also the heterodimer transporter ABCG5/G8, which effectively 
excretes dietary plant sterols and to a lesser extent, cholesterol, back into the intestinal 
lumen (Table 1). The balance between the activities of the NPC1L1 and ABCG5/G8 
transporters is thought to regulate the efficiency of intestinal cholesterol absorption (Yu et 
al. 2002, Duan et al. 2004), although genetic deletion of the ABCG5/8 does not affect 
baseline m-RCT in mice (Calpe-Berdiel et al. 2008). Once transported inside the enterocytes, 
cholesterol can be esterified and packaged into chylomicrons with apoB-48 (apoB-100 in 
mice) to be returned via lymphatics into the systemic circulation (Hussain 2000), or it may 
be effluxed through the basolateral ABCA1-transporter to apoA-I to be delivered via the 
portal veins back into the liver. 
3.4 Novel aspects of RCT 
As described above, since the initial conceptualization of the RCT pathway, most of the key 
cholesterol and bile acid transporters participating in the process have been identified. 
Recently, new details have also been revealed regarding the overall process of cholesterol 
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transport from peripheral tissues into the circulation. Namely, emerging evidence suggests 
that lymph plays a significant role in the transport of cholesterol (Lim et al. 2013, Martel et 
al. 2013): Lymphatic cholesterol is thought to travel in HDL, which can be actively taken up 
by the lymphatic vascular walls (Lim et al. 2013). If lymphatic vasculature is disrupted, RCT 
from the skin, and notably, from aortic plaques, is markedly diminished in mouse models. 
Conversely, disruption of the endothelial barrier by vasoactive compounds in the skin 
enhances the passage of HDL into the interstitial fluid and thus increases the rate of RCT 
from peripheral macrophage foam cells (Kareinen et al. 2014). Interestingly, studies in 
human peripheral lymph showed that the concentrations and activities of enzymes that 
take part in HDL maturation differ in blood and lymph. Importantly, the formation of preβ-
HDL at the expense of α-HDL particles is preferred in the lymph, which is thought to 
facilitate cholesterol efflux and RCT from peripheral cells (Miller et al. 2013).  
Recently, another novel, mostly HDL-independent pathway for cholesterol transfer from 
blood into feces was described in mice lacking bile secretion (Kruit et al. 2005, van der 
Velde et al. 2008, Temel et al. 2010). This alternative cholesterol transport process, termed 
trans-intestinal cholesterol excretion (TICE), involves direct uptake and excretion of 
circulating cholesterol by the small intestine and may account for up to a third of fecal 
cholesterol excretion in mice (van der Velde et al. 2008). The exact mechanism and the 
mediating transporters are still mostly unknown; however, it has been shown that TICE can 
be stimulated by LXRα (van der Veen et al. 2009) and that it requires energy and a 
functional LDL-receptor at the basolateral side of enterocytes (Le May et al. 2013). There is 
emerging evidence that TICE exists also in humans and may contribute notably to RCT 
(Jakulj et al. 2013). Recent advances in the methodology for measuring RCT in humans have 
also revealed that non-HDL lipoproteins may contribute much more to RCT than has been 
so far thought (Holleboom et al. 2013). 
3.5 Molecular regulation of cholesterol and bile acid homeostasis 
A 70-kg human loses on average 1 g of cholesterol and 0.4 g bile acids in feces every day  
(Grundy et al. 1965). This equals about 0.7% of cholesterol in the whole body (Cohen 2008). 
Mice, having a higher metabolic rate, replace daily approximately 7% of their whole-body 
cholesterol pool (Xie et al. 2009). In a steady state, the balance between the dietary intake, 
hepatic production, and fecal excretion of cholesterol and bile acids is tightly regulated by a 
number of nuclear receptors that adjust hepatic and intestinal gene transcription (Table 2). 
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The fundamental roles of nuclear receptors in the regulation of RCT have been revealed by 
genome-wide expression profiling and functional analyses conducted in animals where the 
functionality of these receptors has been modified. 
  
Table 2. The effects of selected members of the nuclear receptor (NR) superfamily of ligand-activated 
transcription factors on components of RCT in mice 
 LXRα (NR1H3)  FXR (NR1H4)   PPARα (NR1C1)      GR (NR3C1) 
Physiological ligand Oxysterols     Bile acids    Fatty acids Glucocorticoids 
Cholesterol      
Efflux from macrophages       ↑          NA           NA          (↓)
g)
 
Trans-hepatic flux        ↑          ↑           ↓            0 
Intestinal absorption       ↓         (↓)
c)
           ↓           ↓  
Total m-RCT in mice       ↑         NA           ↑           ↑ 
Bile acids     
Synthesis (CYP7A1)    ↑ (↓)
a)
          ↓           ↓         ↓↑ 
Intestinal absorption (ASBT)       NA         (↓)
d)
          (↑)
f)
           ↑ 
Trans-hepatic flux (NTCP)       NA          ↓           ↓           ↑ 
h)
 
Biliary secretion (BSEP)        0          ↑            0         ↑↓
i)
 
Interactions between the 
transcription factors 
  PPARα ↑ 
  GR ↓
b)
 
LXRα ↑
e)
 
PPARα ↑ 
LXRα ↑↓ 
      GR ↓ 
      PPARα ↑ 
      FXR ↓
j)
 
 LXRα ↓↑
k)
 
LXRα = liver X receptor α, FXR = farnesoid x receptor, PPARα = peroxisome proliferator activated 
receptor α, GR =glucocorticoid receptor, NA = data not available, 0 = no effect. According 
observations made during the studies of this thesis are bolded. 
a) Downregulation only in humans, see Section 3.5.3 for references 
b) Selective inhibition of certain GR-stimulated genes by LXRα (Stulnig et al. 2002, Nader et al. 2012) 
c) In mice but not in hamsters (Gardes et al. 2013) 
d) In mice but not in rats  (Chen et al. 2003) 
e) Upregulation of LXRα upon bile acid feeding requires FXR (Sinal et al. 2000) 
f) Human Caco-2 colonic cancer cell line treated with a PPARα agonist  (Jung et al. 2002) 
g) Dexamethasone-treatment in cultured macrophages reduced ABCA1  (Ayaori et al. 2006) 
h) Reported in GR-KO mice (Rose et al. 2011) and in human hepatocytes (Eloranta et al. 2006) 
i) Species-specific effect which varies with agonist used (Rosales et al. 2013) 
j) Impaired transactivation function of FXR, target gene-specific (Lu et al. 2012b) 
k) Study II: Lxrα was upregulated by corticosterone in macrophages; Study III: liver Lxrα was reduced 
by subchronic stress. Rest of the references can be found in sections 3.5.1 - 3.5.3, 5.2 and Results and 
Discussion. 
 
In addition, regulatory mechanisms not mediated via transcription factors have been found. 
For example, a microRNA produced from an intron of the SREBP2- gene, miR-33, was 
recently identified as an important repressor of the cholesterol transporter ABCA1 in both 
mice and humans (Rayner et al. 2010). Accordingly, systemic silencing of miR-33 promoted 
RCT in a mouse model (Rayner et al. 2011).  
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3.5.1 Regulation of RCT by the LXRα 
From the plethora of molecules that participate in the maintenance of systemic cholesterol 
homeostasis, the transcription factor liver X receptor α (LXRα) is the key regulator of m-RCT 
(Peet et al. 1998). LXRs are members of the nuclear hormone receptor superfamily that 
bind both steroidal and non-steroidal ligands. Of the two subfamilies of LXRs, the 
expression of LXRα is limited to metabolically active tissues such as liver, adipose tissue, 
kidney, intestine, and spleen, whereas the expression of LXRβ is more ubiquitous. After 
binding to their activators, such as mono-oxygenated derivatives of cholesterol known as  
oxysterols (Lehmann et al. 1997), LXRs couple with another transcription factor, retinoid X 
receptor (RXR), and move into the nucleus where they regulate several genes that control 
cholesterol, glucose and fatty acid metabolism (Stulnig et al. 2002, Steffensen et al. 2004). 
The key function of LXRα is to act as a cholesterol sensor: when cellular oxysterols 
accumulate as a result of increasing concentrations of cholesterol, the LXRα-RXR dimer 
induces the transcription of genes that protect cells from cholesterol accumulation (Table 
2) and participates in the reduction of cholesterol synthesis (Tobin et al. 2002). Regarding 
m-RCT, the most important stimulated targets of LXRα are the ABCA1 and ABCG1 in 
macrophages as well as the ABCG5/8 in the liver and small intestine (Plosch et al. 2002, 
Kruit et al. 2005, Calpe-Berdiel et al. 2008). Induction of LXRα by short-term cholesterol 
feeding also leads to an increase in the transcription of hepatic CYP7A1 and a reduction in 
that of the intestinal NPC1L1 in mice (Kruit et al. 2005, Henkel et al. 2011). Notably, this 
effect is species-specific: human LXRα has a suppressive effect on CYP7A1 transcription 
(Goodwin et al. 2003) and therefore, increase in dietary cholesterol does not generally 
promote bile acid formation in humans. Altogether, LXRα activation promotes m-RCT by 
increasing cholesterol efflux from macrophages, by stimulating cholesterol excretion into 
bile and possibly, depending on the species, by stimulating the conversion of cholesterol 
into bile acids and by inhibiting cholesterol reabsorption in the intestine. 
3.5.2 Regulation of bile acid homeostasis by the FXR 
Bile acids are not only crucial for the intestinal absorption of cholesterol, lipid-soluble 
vitamins (A, D, K, and E), and, to a lesser extent, of triglycerides and fatty acids, but they 
also serve as important metabolic signaling molecules (Watanabe et al. 2004). On the other 
hand, primary bile acids, such as cholic acid, and all secondary bile acids are highly toxic to 
living cells when present in high concentrations. For the above reasons, the synthesis and 
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excretion of bile acids is tightly regulated by elaborate negative feedback mechanisms. The 
main mediator of the regulatory process is the bile acid-binding nuclear hormone receptor 
farnesoid X receptor (FXR) which is highly expressed in the liver, intestine, kidneys, and the 
adrenal glands (Makishima et al. 1999). If the negative feedback regulatory cycle is 
disrupted due to FXR deletion, the synthesis and steady-state pool size of bile acids increase 
markedly (Kok et al. 2003).  
Although FXR is, similar to LXRα, able to directly bind DNA via specific response elements, it 
often exerts its actions via mediators (Figure 4). For instance, to inhibit hepatic bile acid 
synthesis, FXR first activates the nuclear factor short heterodimer partner (SHP) to suppress 
the activities of liver receptor homologue 1 (LRH-1) and LXRα, which finally results in the 
inhibition of the CYP-enzymes (Peet et al. 1998, Goodwin et al. 2000). In the intestine, the 
bile acid-activated FXR interacts independently of SHP with fibroblast growth factor 15 
(FGF15/FGF19 in humans) to suppress CYP7A1 (Holt et al. 2003). The crosstalk between the 
liver and the intestine is further emphasized by the fact that intestinal FGF15 also controls 
gallbladder filling and inhibits gallbladder emptying by opposing the action of 
cholecystokinin (Choi et al. 2006).  
In addition to the negative feedback circuits that regulate bile acid synthesis, several 
additional regulatory mechanisms control the various steps of bile acid uptake, 
transportation, and reabsorption in the liver and intestine (Table 2 and Figure 4). FXR, 
either directly or indirectly via SHP or other mediators, has been implicated in the 
repression of hepatic NTCP (Eloranta et al. 2006) and intestinal ASBT (Chen et al. 2003), and 
in the stimulation of hepatic BSEP and MRP2 (Moschetta et al. 2004), SR-BI (Chao et al. 
2010, Li et al. 2012b), and intestinal ILBP (Kok et al. 2003) and OSTα-OSTβ (Zollner et al. 
2006) (Figure 4). Besides FXR, the pregnane X receptor (PXR), which is activated by the 
secondary bile acid lithocholic acid, participates in bile acid detoxification and promotes 
CYP7A1, ASBT, and BSEP expression in mice (Teng and Piquette-Miller 2005, He et al. 2011). 
Also the glucocorticoid receptor (GR) may regulate the enterohepatic circulation of bile 
acids (Table 2). Stimulation of the receptor in experimental animals by synthetic 
glucocorticoids has been shown to promote transcription of ASBT (Coon et al. 2010), BSEP 
(Rosales et al. 2013), and NTCP (Simon et al. 2004, Rose et al. 2011). 
 24 
 
Figure 4. Schematic summary of the effects of the liver x receptor alpha (LXRα), farnesoid x receptor 
(FXR), and other transcription factors on components of RCT in mice. Inhibiting effects are marked 
with red lines and stimulating effects with black arrows. The transcription factors short heterodimer 
partner (SHP), liver receptor homologue 1 (LRH-1), and fibroblast growth factor 15 (FGF15) function 
downstream of FXR. They may also act as mediators between FXR and LXRα. Genes regulated by the 
glucocorticoid receptor (GR) may affect all major steps of m-RCT. The transcription factors pregnane x 
receptor (PXR) and peroxisome proliferator activated receptor alpha (PPARα) are important 
regulators of cholesterol and bile acid transporter proteins in the liver and intestine. References and 
details of the regulatory cascades can be found in the main text and in Table 2.  
3.5.3 LXR and FXR at the crossroads of cholesterol and bile acid metabolism 
Conversion of cholesterol into bile acids is the only quantitatively important pathway to 
catabolize cholesterol. As mentioned above (Section 3.5.1), dietary cholesterol intake and 
high levels of cellular cholesterol stimulate bile acid synthesis via LXRα in mice. Regulatory 
mechanisms acting in the opposite direction exist as well: when cellular cholesterol is low, 
the microRNA miR-33 represses the transcription of BSEP and biliary bile acid secretion 
(Allen et al. 2012), while its parent gene SREBP2 promotes bile acid absorption via ASBT 
(Thomas et al. 2006). These changes reduce the fecal wasting of both cholesterol and bile 
acids. 
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Conversely, bile acids and FXR are involved in the regulation of cholesterol and lipoprotein 
homeostasis (Table 2 and Figure 4). FXR agonists are found to lower circulating cholesterol 
levels and reduce atherosclerosis in vivo (Evans et al. 2009, Hartman et al. 2009, Hambruch 
et al. 2012). Several explanations for this have been proposed: De Aguiar Vallim et al (2013) 
showed that FXR activation results in the production of a microRNA miR-144, which may, by 
downregulating ABCA1 in hepatocytes, inhibit cholesterol transfer to apoA-I and promote 
the channeling of cholesterol to biliary secretion via ABCG5/8. FXR may also directly 
upregulate the hepatic SR-BI receptor (Chao et al. 2010, Li et al. 2012b), thereby increasing 
cholesterol flux into bile (Figure 4). In human hepatic and intestinal cell lines, FXR activation 
by synthetic agonists (Sirvent et al. 2004) and bile acids (Nakahara et al. 2002) has been 
shown to promote LDL- and VLDL-receptor expression. If this would occur in vivo, it would 
increase the clearance of circulating cholesterol. Finally, the synthesis rate of bile acids and 
cholesterol may be co-regulated by cholesterol metabolites. Namely, enzymes of the bile 
acid synthesis pathway, especially CYP27A1 (Zurkinden et al. 2014), produce oxysterols 
which, by activating LXRα and suppressing SREBP2 functionality, hinder the activity of 3-
hydroxy-3-methyl-glutaryl-CoA reductase, the key enzyme of the cholesterol synthesis 
pathway (Sharpe and Brown 2013).  
4. Mast cells  
Mast cells are bone marrow-derived immune cells whose main function is to guard the 
body against foreign invaders as a part of the innate immune system.  After exiting the 
bone marrow as immature precursors, mast cells move via circulation into tissues to 
complete their maturation (Rao and Brown 2008). Mast cells were described and named by 
Paul Ehrlich in 1877. The name mast cell is derived from numerous electron-dense 
cytoplasmic granules that give the cells an overfed appearance. The mast cell granules are 
secretory lysosomes which are packed with negatively charged sulphated proteoglycans 
and various active mediator substances. Mast cells reside in large numbers in tissues at the 
interfaces of the body and the external environment (the skin, airways, gastrointestinal 
tract, and vasculature), where they protect from bacterial infections and act to maintain 
tissue integrity as well as local hemodynamics and homeostasis. 
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4.1 Functional reactivity of mast cells  
Mast cells exert their biological functions through the release of an array of mediators in 
response to activating stimuli. Mast cells contain several receptors that react to 
immunological cues. Immunoglobulins (Ig), especially IgE (the major mediator of immediate 
hypersensitivity reactions), components of bacteria, viruses, and complement proteins bind 
to the high-affinity IgE/IgG receptors, toll-like receptors, and complement receptors on the 
mast cell membrane, respectively (Rao and Brown 2008). In addition, cytokines such as the 
monocyte chemotactic protein 1, produced by macrophages and lymphocytes, may activate 
mast cells (Alam et al. 1994). Non-immunological activator signals of mast cells include 
modified lipoprotein-IgG complexes (Lappalainen et al. 2002), basic substances such as 
compound 48/80 (Huang et al. 2002), and neuropeptides such as substance P (Ebertz et al. 
1987). The physiological relevance and mechanisms of mast cell activation by non-
immunological stimuli are not always well-understood. Substance P and compound 48/80 
are thought to activate mast cells receptor-independently by directly stimulating a G-
protein signaling cascade (Mousli et al. 1990), whereas some activators, such as modified 
lipoproteins, may bind to the immunological receptors (Meng et al. 2013). In many tissues, 
mast cells are important mediators between the nervous and immune systems: for 
example, it is estimated that 70% of intestinal mucosal mast cells are in direct contact with 
nerves (Stead et al. 1989). This helps to explain the potency of psychological stress as an 
activator of mast cells (Spanos et al. 1997, Singh et al. 1999, Huang et al. 2002), a concept 
that is introduced further in Section 5.3. 
Mast cells are extremely plastic and adapt the synthesis and release of their mediators to 
surrounding activator signals and conditions (Pejler et al. 2007). Secretory products of mast 
cells are divided into two classes: the first class includes preformed molecules that are 
stored in the cytoplasmic granules and can be released within seconds after fusion of the 
granules with the cell membrane. The full effects of the preformed mediators are exerted 
within 15 minutes of mast cell activation (Metcalfe et al. 1997). Such mediators include 
histamine, the neurotransmitter serotonin (Kushnir-Sukhov et al. 2007), proteases, and 
certain cytokines. The synthesis of the second class of mast cell mediators starts after mast 
cells have become activated. The non-preformed mediators include various eicosanoids, 
cytokines, and chemokines, which induce vascular, inflammatory, and immunomodulatory 
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effects that typically peak in 6-12 hours after the initial activation signal (Metcalfe et al. 
1997). 
Histamine is a biogenic amine that activates tissue-specific histamine receptors. Local 
histamine release induces vasodilation, vascular permeability, and leucocyte adhesion 
(Thurmond et al. 2008). Moreover, mast cells may exert pro-angiogenic effects, for 
example, by secreting vascular endothelial growth factor (Boesiger et al. 1998). The most 
abundant mast cell-specific proteases are the neutral serine proteases, chymases and 
tryptases. Other types of proteases found in mast cells include renin, cathepsin G and 
carboxypeptidase A, the last of which is also mast cell-specific and is retained in the same 
granules with chymases (Goldstein et al. 1992). Mast cells can be classified based on their 
location. For instance, mouse mast cells are divided into mucosal and connective tissues 
types: the former occupy the mucosal lining of the gut while the latter reside in the skin and 
peritoneum (Pejler et al. 2007). On the other hand, mast cells can also be classified based 
on their protease pool (Pejler et al. 2007). Chymases are the most abundant proteases in 
rodent peritoneal mast cells (Lutzelschwab et al. 1997) and they can be found in 40% of 
mast cells present in human coronaries (Kaartinen et al. 1994b). In addition to chymases, 
connective tissue mast cells express high amounts of tryptases, whereas mucosal mouse 
mast cells typically contain only chymases  (Reynolds et al. 1990).  
4.2 Substrates of mouse mast cell proteases  
After degranulation, mast cell proteases remain bound to the heparin proteoglycans which 
is thought to protect them from protease inhibitors such as α1-antitrypsin and α1-
antichymotrypsin. For instance, heparin-bound, but not free, chymase retains its proteolytic 
activity after degranulation in vitro in human aortic intimal fluid (Lindstedt et al. 2001). 
Eventually, mast cell granule remnants can be phagocytosed by neighboring macrophages 
which will quench any proteolytic activity.  
Mast cell proteases have broad cleavage specificities and their physiological effects can be 
either protective or detrimental. The substrates of chymase include angiotensin I (Reilly et 
al. 1982), extracellular matrix proteins such as fibronectin (Vartio et al. 1981), apoE, apoA-I, 
apoA-II, and PLTP (Lee et al. 2003b, Judström et al. 2010). Importantly, lipid-free and lipid-
poor apoA-I can be cleaved by chymase at several points containing suitably exposed 
aromatic amino acid residues. The tertiary structure of the substrate determines the 
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preferred cleavage site: for example, lipid-free apoA-I is preferentially digested by chymase 
at the C-terminal Phe
229
 and Tyr
192
 -residues (Usami et al. 2012). In comparison, apoA-I in 
discoidal recombinant human HDL, a semisynthetic model for the circulating pre-HDL 
particles, is cleaved by chymase either at the C-terminus (Phe
225
) or at the N-terminus (Tyr
18
 
or Phe
33
)  (Lee et al. 2003a).  
Chymases may have multiple physiological roles as chymotryptic activity has been shown to 
promote mucosal permeability and inflammatory cell recruitment (Scudamore et al. 1995). 
On the other hand, chymases are also able to inactivate venoms and may protect from 
dermatitis (Järvikallio et al. 1997). Tryptases are able to target many of the same substrates 
as chymases; for example, they disrupt endothelial tight junctions (Bankova et al. 2014). 
Mast cell tryptases have been implicated in allergic airway inflammation in both animal and 
human studies (Clark et al. 1995, Berger et al. 1999). 
4.2 Roles of mast cells in atherosclerosis 
On average, 600 mast cells can be found per square mm in human atherosclerotic lesions 
and the degree of their activation is high especially in the shoulder regions of coronaries  
(Kaartinen et al. 1994a, Kovanen et al. 1995). Atherosclerotic plaques contain several 
molecules that may act as local activators of mast cells. These include inflammatory 
mediators secreted by macrophages and lymphocytes, oxidized LDL-IgG immune complexes 
(Lappalainen et al. 2011), neural mediators, and microbes (Oksaharju et al. 2009).  
Comprehensive experimental evidence links mast cell activation to the development of 
atherosclerotic plaques in mouse models. Ilze Bot and coworkers have demonstrated that 
perivascular mast cell activation promotes progression of atherosclerotic plaques in ApoE-
KO mice by inducing intravascular hemorrhages, leucocyte adhesion, and macrophage 
apoptosis, and that enzymatic inhibition of mast cell chymase attenuates these pro-
atherogenic effects (Bot et al. 2007, Bot et al. 2011). In addition to inducing inflammatory 
changes, mast cell proteases are able to modify both the vessel wall proteoglycans and 
lipoprotein particles in a way that promotes LDL accumulation and uptake by macrophages  
(Kovanen 1991). Furthermore, as mast cell tryptases and chymases are able to degrade 
apoA-I of preβ-HDL, mast cell activation may interfere with m-RCT by hampering the 
ABCA1-mediated cholesterol efflux process (Lee et al. 2000, Lee et al. 2003a). Human 
chymase is also capable of inhibiting the activities of PLTP and CETP which may further 
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affect the functionality of HDL particles (Lee et al. 2003b, Lee-Rueckert et al. 2008). Finally, 
mast cells may also directly participate in the triggering of cardiac events by destabilizing 
advanced atherosclerotic lesions. In both mouse models and humans, mast cells have been 
found to secrete and activate matrix metalloproteinases and other proteases that 
effectively remodel the extracellular matrix of the plaques, and to secrete histamine and 
platelet activators that may induce vasoconstriction and trigger the formation of a 
thrombus  (Mäyränpää et al. 2006, Sun et al. 2007, Bot et al. 2013).  
5. Physiology of stress   
The early concept of stress was formulated during the 1930s-1940s by an Austrian-
Canadian endocrinologist Hans Selye. He conducted elaborate experimentation focusing on 
a non-specific, recurrent response of an organism to a stressor, or noxious stimuli, as he 
first defined it (Selye 1936). Selye conceptualized the set of reactions occurring upon stress 
as the “general adaptation syndrome”. According to a current view, the stress reaction 
operates to maintain biological homeostasis, via allostatic regulatory mechanisms, in the 
face of an overpowering challenge (Sapolsky et al. 2000). This protective response involves 
the hypothalamic-pituitary-adrenal (HPA) axis, the autonomic nervous system as well as the 
cardiovascular, metabolic and immune systems.  
5.1 The actions of the HPA-axis and the sympathetic nervous system in stress 
The two major peripheral limbs of the stress system are the HPA axis, operated from the 
hypothalamus, and the sympathetic nervous system (SNS), operated from the brain stem. 
Stress-induced stimulation of the hypothalamic paraventricular nucleus and associated 
brain areas, such as the limbic system, results in portal release of corticotropin releasing 
hormone (CRH) and vasopressin, the main regulators of pituitary adrenocorticotropic 
hormone (ACTH) secretion (Vale et al. 1983). In the pituitary, CRH binds to type 1 CRH-
receptors, which results in the release of ACTH into systemic circulation. Hypothalamic 
vasopressin has a minor role in the induction of ACTH secretion during an acute stress 
reaction, but its role is central during chronic stress, when it becomes the major regulator 
of ACTH release. (Aguilera 1998). Circulating ACTH stimulates the adrenal cortexes to 
secrete glucocorticoids (mostly cortisol in humans and corticosterone in rodents). 
Glucocorticoid is a general name given for steroid-based compounds that regulate the 
metabolism of glucose and are synthetized in the adrenal cortex. Simultaneously with the 
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stepwise, centrally driven activation of the HPA axis and the resulting systemic release of 
glucocorticoids, peripherally produced CRH may act, by binding to type 2 CRH-receptors, as 
a local stress effector in certain tissues. Such localized, regulated stress reactions are known 
to occur especially in the skin (Kono et al. 2001) and in the intestine (Kiliaan et al. 1998). 
5.1.1 The receptors for glucocorticoids 
HPA axis activity and glucocorticoid secretion exhibit circadian rhythmicity, with peak 
hormone concentrations occurring in the beginning of the activity phase (that is, in the 
early morning in diurnal animals such as mice) (Lightman et al. 2008). The temporal 
regulation of basal glucocorticoid release is essential for the cooperation of the central 
metabolic pathways, as well as for the maintenance of stress reactivity (Sarabdjitsingh et al. 
2010).  
Two types of glucocorticoid receptors exist in all tissues: the high-affinity mineralocorticoid 
receptor (MR) and the low-affinity glucocorticoid receptor (GR). Accordingly, low basal 
glucocorticoid levels occupy the MR, whereas high levels, predominantly occurring only 
during a stress reaction, progressively saturate the GR (Arriza et al. 1988). Ligand-binding 
induces homo-dimerization and translocation of the GR-ligand complex into the nucleus 
where it binds to glucocorticoid response elements (GRE) in the promoter regions of 
glucocorticoid-regulated genes. HPA axis activity and glucocorticoid secretion are retained 
under elaborate negative feedback control that occurs on both fast and slow time frames  
(Andrews et al. 2012). The classical, slow negative feedback includes glucocorticoid-
mediated inhibition of CRH and ACTH release in the pituitary and hypothalamus, 
respectively (Keller-Wood and Dallman 1984). The more recently discovered, fast negative 
feedback that limits glucocorticoid secretion is non-genomic and ensues through 
presynaptic cannabinoid receptors (Di et al. 2003, Evanson et al. 2010). Local expression of 
the GR can also be altered by the circulating levels of glucocorticoids in a tissue-specific 
manner (Kalinyak et al. 1987). Moreover, local glucocorticoid metabolism is regulated by 
hydroxysteroid 11-beta dehydrogenase enzymes type 1 and type 2 which catalyze the 
conversion between active 11-hydroxy-glucocorticoids and their inactive 11-keto forms. 
The inactivating type 2 -enzyme is highly expressed in the kidneys which are the key target 
of mineralocorticoids. By locally inactivating glucocorticoids, the enzyme facilitates the low-
affinity binding between mineralocorticoids and the MR. (Funder et al. 1988). 
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5.1.2 Activation of the SNS 
In parallel to the release of glucocorticoids from the adrenal cortex, fast stimulation of the 
SNS leads, through the splanchnic nerve, to the activation of the adrenal medullae, from 
where adrenalin/epinephrine is released into the systemic circulation. In addition, stress 
stimulates peripheral norepinephrine release from sympathetic nerve fibers that heavily 
innervate several tissues. According to current knowledge, there are at least three distinct 
peripheral catecholaminergic systems, each with different effectors, regulation, and roles in 
stress (Kvetnansky et al. 2009). The systemic release of adrenalin and the local release of 
norepinephrine activate α1-, α2-, and β-adrenergic receptors in the target tissues. 
Depending on the tissue type, receptor activation launches diverse second messenger 
cascades to induce both immediate non-genomic and slower genomic actions. Most of the 
immediate effects of stress (stimulation of heart rate, elevation of blood pressure, and 
lipolysis) are derived from the targeted activation of adrenergic receptors. (Kvetnansky et 
al. 2009). 
5.2 The stress reaction induces central changes in energy metabolism via PPARα 
The stress-induced surge of glucocorticoids and catecholamines into circulation induces 
fundamental changes in metabolism. Liver is the main target of these stress mediators due 
to its central role in energy homeostasis: global expression screening has revealed that the 
expression of at least 400 hepatic genes, many of which are involved in the metabolism of 
carbohydrates, lipids and protein, changes when mice are subjected to acute and repeated 
restraint stress (Depke et al. 2008). 
Among the first events after the activation of the stress axes is the release of glucose from 
hepatic glycogen stores into circulation to meet the increased energy demands of muscles 
and the nervous system. Simultaneous induction of insulin resistance in the liver, muscle, 
and adipose tissues ensures that the released glucose is not stored back into tissues  
(Frohman and Bernardis 1971, Rizza et al. 1982). Hepatic gluconeogenesis is activated 
through stimulation of the transcription rate of glucose-6-phosphatase, a key enzyme in 
gluconeogenesis, to maintain the availability of glucose. The fuel for gluconeogenesis is 
provided in the form of amino acids, fatty acids, and glycerol, the supply of which is driven 
by the catabolic action of catecholamines and glucocorticoids in muscle and adipose tissue. 
(Sapolsky et al. 2000). For example, intracellular hormone sensitive lipases in adipocytes are 
stimulated by adrenalin and ACTH, which results in hydrolysis of triacylglycerols. The 
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liberated fatty acids can be consumed not only by gluconeogenesis, but also by β-oxidation 
in the liver and muscle tissue.  
The peroxisome proliferator receptors (PPARs) α, δ, and γ are transcription factors that act 
as sensors for fatty acids and control the activity of the major metabolic pathways involved 
in lipid and glucose metabolism. Of the receptors, PPARα is predominantly expressed in 
tissues that are capable of oxidizing fatty acids, such as brown adipose tissue, liver, heart, 
and muscle (Kliewer et al. 1994). PPARα is the key mediator of the glucocorticoid-induced 
elevation of blood pressure and induction of hepatic gluconeogenesis and insulin resistance 
in mice (Bernal-Mizrachi et al. 2003). Hepatic PPARα expression is strongly stimulated by 
adrenocorticoid receptor activation in physiological stress (Konstandi et al. 2013), and its 
basal expression parallels that of circulating corticosterone (Lemberger et al. 1996), 
suggesting that stress hormones are able to directly activate PPARα already before its 
induction by released fatty acids. Moreover, conversation between PPARα and the HPA axis 
appears to be bidirectional; that is, PPARα activation triggers corticosterone production and 
hepatic GR downregulation in rats and mice (Chen et al. 2008, Wang et al. 2010, Konstandi 
et al. 2013) (Table 2).  
If prolonged or cumulative increases in glucocorticoid secretion occur, adverse metabolic 
consequences may arise. For example, chronic stress-induced insulin resistance promotes 
hyperglycemia, loss of muscle tissue, and modification of adipose tissue distribution (Kuo et 
al. 2007). Epidemiologically, chronic stress is a risk factor for the metabolic syndrome which 
is characterized by obesity, elevated blood pressure, dyslipidemia (Fabre et al. 2013), 
impaired glucose tolerance, and a chronic inflammatory state (Bergmann et al. 2014). 
Chronic secretion of the HPA-axis-derived hormones may also evoke complex endocrine 
changes by inhibiting the release of gonadotrophins (Ariznavarreta et al. 1989), the growth 
hormone, and the thyroid stimulating hormone (Marti et al. 1993).  
5.3 The intestine is a target of both systemic and neural stress mediators 
Intestine is another organ that is strongly affected by stress. This is reflected by the fact that 
psychological stress is a predisposing factor for the onset of gastrointestinal diseases such 
as irritable bowel syndrome and various inflammatory bowel diseases. At the intestinal 
epithelium, stress may hamper the expression of endothelial tight junction proteins 
(Demaude et al. 2006, Zheng et al. 2013) and activate mast cells in the lamina propria by 
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inducing targeted CRH secretion (Santos et al. 2008). Mast cell activation results in the 
release of histamine, proteases, and tumor necrosis factor α (TNF-α) that are capable of 
disrupting the epithelial barrier (Overman et al. 2012). In effect, intensive stress increases 
epithelial permeability to ions, sugars, small proteins, and bacteria both in humans and 
animals (Kiliaan et al. 1998, Ferrier et al. 2003, Mazzon et al. 2009, Vanuytsel et al. 2014). 
The absorptive functions of the gut may also be affected by stress-induced alteration in 
gastrointestinal motor activity. Acute stress decreases gastric motility in mice (Babygirija et 
al. 2011), which can be attributed to the gastric type 2 CRH receptors and activity of SNS 
(Lenz et al. 1988b, Martinez et al. 2004, Nakade et al. 2005). Similarly, stress and adrenergic 
activation may decrease the motility of the small intestine  (Lenz et al. 1988b), yet the 
effect is less prominent than in the stomach probably due to a lower density of vagal 
innervation in the small intestinal wall. According to an in vivo study, both the slower gastric 
emptying and retardation of small intestinal transit time might promote cholesterol 
absorption (Wang et al. 2004). Large intestinal motility is strongly stimulated by acute 
stress. Hypothalamic CRH secretion activates parasympathetic and motor neurons, which 
stimulate enteric muscle function (Lenz et al. 1988a). Enteric motor neurons may also 
directly respond to peripheral CRH through type 1 CRH receptors (Lenz et al. 1988b, 
Martinez et al. 2004). The acceleration of colonic transit is normally attenuated as stress 
exposure becomes chronic  (Gourcerol et al. 2009, Babygirija et al. 2011). Overall, 
stimulated colonic motility, or even ileal exclusion, do not notably interfere with cholesterol 
absorption which is mainly restricted to the duodenum (Åkerlund et al. 1994). On the 
contrary, many secondary bile acids such as litocholic acid and deoxycholic acid, which are 
formed by intestinal bacteria, are passively absorbed in the large intestine. This renders 
their absorption particularly susceptible to stress-induced perturbations in colonic transit 
rates (Dowling et al. 1997, Veysey et al. 2001).  
6. Stress models in animal studies and the role of habituation  
The endocrinological stress response and many of its primary protein targets are well 
conserved across the animal kingdom, which reflects the fundamental role of the stress 
response in survival. Diverse homeostatic challenges can evoke a stress response, including 
cold, infection, hemorrhage, pain, emotional distress, and sleep deprivation. Several animal 
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models have been developed to study the details of the stress reaction and to mimic 
different stress-evoking conditions encountered during human life. 
The various stress models can be categorized as social, physical, or psychological, yet the 
nomenclature is not fixed and the categories overlap extensively (Table 3). For instance, 
psychological stress is universally defined as a “perceived challenge to well-being”  
(Sapolsky et al. 2000). This interpretation excludes purely physical/systemic stressors such 
as hemorrhage or infection, but includes all social and mental stressors (Table 3).  
Table 3. Classification of common stressors used in animal studies 
Type of stress Stressor examples in rodents Stressor examples in humans 
Physical Hemorrhage, infection Occult infections 
Psychological  Predator odour, noise Work stress, economical 
concerns 
Social + psychological 
(=psychosocial) 
Social isolation, social defeat stress Divorce, discrimination, public 
speaking 
Physical + psychological 
(=psychophysical) 
Restraint/immobilization, forced 
swimming, electric foot shocks 
Hunger, somatic disease, 
sleep deprivation 
 
Although the stress reaction can be described as a pre-programmed set of events, subtle 
differences exist in the responses of the endocrine and nervous systems to distinct 
stressors: for example, CRH receptor activation in the brain (Luo et al. 1994) and the 
pattern of the endocrine response (Pacak et al. 1998) may vary according to the type of 
stressor applied. Social disruption stress in rodents typically produces robust alterations in 
the immune system along with an increase in the intake of high-calorie foods (Tamashiro et 
al. 2007, Hanke et al. 2012), whereas a procedure termed chronic unpredictable stress 
(CUS), which includes mainly psychophysical stressors, induces a depression-like state with 
reduced appetite and locomotor activity (Bondi et al. 2008).  
The duration, interval and predictability of stress have a substantial impact on the total 
strain experienced by an organism. This is because hormonal and behavioral responses to 
repeating homotypic stressors exhibit habituation, characterized by the desensitization of 
the elements of the stress pathway and the progressive decrease in the strength of the 
response (Keeney et al. 2006). The degree of habituation depends on the type and 
presentation schedule of stressors (Aguilera 1998). On the other hand, previous exposure 
to a powerful or long-lasting stressor may sensitize the HPA-axis to the same or a different 
stressor, a mechanism at least partially mediated by hypothalamic vasopressin (Aguilera 
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1998, Cassano and D'mello 2001). According to clinical studies, even a single highly 
traumatic event in childhood may produce prolonged neuroendocrine sensitization to 
stress (Heim and Nemeroff 2001).  
7. Epidemiological and animal data connecting stress to 
atherosclerosis 
The drastic activation of the SNS in acute stress elevates heart rate and blood pressure, and 
induces platelet activation and hemoconcentration (Musumeci et al. 1987, Plourde et al. 
2013). Acute stress-induced endothelial dysfunction may also interfere with local blood 
flow by triggering vasoconstriction and by impairing local nitric oxide production 
(Chumaeva et al. 2009). All such changes may induce arrhythmias and plaque rupture which 
may precipitate myocardial infarction and stroke especially among patients with advanced 
heart disease (Deanfield et al. 1984, Leor et al. 1996). Apart from this rather clear 
association between stress and cardiac events in patients already suffering from heart 
disease, the overall role of stress in atherosclerosis development has remained unclear 
despite several investigations conducted on the topic. One confounding factor may be the 
difficulty in quantifying chronic stress in epidemiological studies which may result in biased 
results (Macleod et al. 2002).  
7.1 Human studies 
Young men who exhibit impaired cardiac recovery from an acute mental task, a typical 
indicator of a chronic stress burden, show clearly increased carotid intima media thickness, 
a surrogate measure for atherosclerosis, when compared to men who do not exhibit signs 
of exhaustion upon acute stress exposure (Chumaeva et al. 2009). Epidemiologically, the 
strongest connection between stress and coronary heart disease has been established in 
studies evaluating work stress (Kivimaki et al. 2012). Occupational stress, defined as an 
effort-reward imbalance or low control/predictability in the working environment, is an 
independent risk factor for atherosclerosis (Greenlund et al. 2010), coronary artery disease 
(Bosma et al. 1997, Hintsa et al. 2010, Nabi et al. 2013), and myocardial infarction and 
stroke (Väänänen et al. 2008, Toren et al. 2014) especially among male workers in blue-
collar occupations. Workers suffering from chronic occupational stress also exhibit more 
atherogenic LDL/HDL cholesterol ratio than non-stressed workers (Siegrist et al. 1988, Peter 
et al. 1998). In women, the connection between work stress and atherosclerosis is less 
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clear, whereas other types of stressors such as marital stress have been shown to associate 
with coronary events (Orth-Gomer et al. 2000). Depression, which is often associated with 
chronic hypercortisolemia, is an independent predictor for coronary death and myocardial 
infarction in both men and women (Rugulies 2002).  
Symptoms associated with prolonged, excessive production of cortisol, typically evoked by 
an ACTH-secreting pituitary tumor, are described as Cushing's syndrome. Cardiovascular 
complications are common among Cushing’s disease patients who also suffer from 
hypertension, depression, and several other risk factors of atherosclerosis (Sugihara et al. 
1992, Arnaldi et al. 2010, Feelders et al. 2012). Glucocorticoids are effective modulators of 
the immune system (van der Sluis et al. 2012), thus their synthetic derivatives are used to 
treat various chronic inflammatory diseases such as rheumatoid arthritis. However, in 
addition to several metabolic side-effects, high use of glucocorticoid-based drugs may 
induce a state of glucocorticoid resistance which is associated with increased inflammation 
due to decreased anti-inflammatory feedback (Miller et al. 2008). This could explain why a 
positive association between glucocorticoid treatment and cardiovascular disease emerges 
among patients taking the largest doses of glucocorticoids (Wei et al. 2004, Bernatsky et al. 
2005). 
7.2 Animal studies 
Atherosclerosis has been studied in animal models for decades. Stress exposure has been 
shown to promote atherosclerosis in monkeys (Kaplan et al. 1983), rabbits (McCabe et al. 
2002, Lu et al. 2012a), and mice (Kumari et al. 2003, Zhang et al. 2010). In mice, the 
circulating levels of atherogenic lipoproteins are low due to absence of CETP and thus, mice 
do not exhibit spontaneous atherosclerosis. The current mouse models of atherosclerosis 
are based on genetic manipulations: LDL receptor-knock out (KO), apoE-KO (Plump et al. 
1992), and the apoE3-Leiden transgenic mice (van den Maagdenberg et al. 1993) develop 
atherosclerotic lesions in the aorta and brachiocephalic artery in only 4-8 weeks when fed a 
diet high in cholesterol and saturated fat. 
Importantly, from the vast number of different stress models applied in animal studies 
(Section 6), not all are equally atherogenic (McCabe et al. 2002, Bernberg et al. 2009). An 
array of studies has also been conducted in animals treated with synthetic glucocorticoids. 
While increased atherosclerosis was observed in one study that used corticosterone-
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treated apoE-KO mice (Okutsu et al. 2014), a finding that is supported by human 
epidemiological data, other studies with dexamethasone-fed rabbits (Asai et al. 1993) and 
corticosterone-treated CETP-ApoE3-Leiden mice (Auvinen et al. 2013) have not shown such 
results. These studies actually demonstrated a reduction in diet-induced atherosclerosis 
and plaque foam cell content in glucocorticoid-treated animals suggesting that, in contrast 
to several stressors, glucocorticoid treatment may even be anti-atherogenic in certain 
animal models. The mechanism might be at least partially mediated by the glucocorticoid-
induced alterations in macrophage function (Auvinen et al. 2013). 
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III Aims of the study 
To investigate the physiological modulations of the reverse cholesterol transport pathway, 
this study utilized an in vivo mouse m-RCT model to answer the following questions:  
1) Does the proteolytic enzyme chymase, secreted from activated mast cells, affect 
the functionality of HDL in m-RCT?   
2) How does an established atherosclerosis risk factor, psychological stress, affect m-
RCT? 
3) What are the mechanisms of m-RCT stimulation under different regimes of 
psychological stress? 
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IV Methods 
Methods used in this thesis are summarized in Table 4. Detailed Materials and Methods are 
presented in the original publications (I-III), and only the key procedures and the methods 
used to obtain unpublished results presented in this thesis are described in detail below. 
Table 4. The main in vivo and in vitro methods applied in this thesis 
Method Study Reference / Source 
In vivo protocols and analyses   
Acute restraint stress (3h) II  
Subchronic and chronic restraint stress regimes II, III  
Macrophage-to-feces RCT I, II, III Calpe-Berdiel et al. 2008 
Hepatic and intestinal cholesterol synthesis II Feingold and Grunfeld 1987 
Hepatic uptake of HDL II Julve et al. 2002 
Cholesterol absorption (fecal dual isotope method) II, III Wang et al. 2003 
Peritoneal mast cell activation I Judström et al. 2010 
Bile acid absorption ([
3
H]taurocholate distribution) III Mendez-Gonzalez et al. 2010 
Ex vivo and in vitro work   
Cholesterol efflux from J774 macrophage foam cells I, II  Judström et al. 2010 
Measurement of chymotryptic activity  
in mouse peritoneal mast cell lysates 
I  Judström et al. 2010 
Measurements (ELISA) of serum stress hormones II, III IBL International and NovaTeinBio 
FPLC fractionation of serum I, II Rotllan et al. 2005 
Measurements of serum lipids I, II, III Roche Diagnostics 
Measurement (ELISA) of apoA-I in mouse serum and 
peritoneal fluid 
I, II van Haperen et al. 2000 
Preparation of phospholipid vesicles I Setälä et al. 2007 
Extraction and enzymatic measurement of bile acids III Diazyme Laboratories 
In vitro proteolysis of apoA-I by mouse chymase I Judström et al. 201) 
Quantitative RT-PCR I, II, III Calpe-Berdiel et al. 2008 
2D immunoelectrophoresis of serum II van Haperen et al. 2000 
Western blotting I, II, III  
Gas-liquid chromatography analysis  
of fecal bile acids and neutral sterols 
III Grundy et al. 1965,  
Miettinen et al. 1982. 
1. Mice, restraint stress regimes and the western diet  
9-13-week old female and male C57BL/6JOlaHsd mice were from Harlan Laboratories 
(Venray, Netherlands). Female mast cell-deficient Kit
W-sh/W-sh
 (“SASH”) mice and PPARα-KO 
mice were purchased from the Jackson Laboratory. LXRα-KO mice were kindly donated by 
Dr. David Mangelsdorf (UT Southwestern Medical Center, Dallas, TX). All genetically 
manipulated mice were created on the C57Bl/6J background. Mice were housed five per 
cage under controlled conditions for light/dark cycle, temperature and humidity. The 
animals were kept in the final animal facility for at least 1 week before the experiments. 
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The mice were fed ad libitum a standard chow diet (2016 Teklad Global, Harlan 
Laboratories) or a Western-type diet (TD.88137, Harlan Laboratories). Food consumption 
was recorded by weighing the food pellets daily.  
Mice in different experiments were stressed by placing them in plastic restraint cylinders 
(Harvard Apparatus, Cambridge, MA) for 30 minutes, one hour, two hours or three hours at 
a time, between 8:00 and 20:00. Depending on the experiment, restraint was repeated for 
1, 3, 7, 16 or 34 times during one day, 5-7 days, 2 weeks, or 9 weeks (Table 5). Interval of 
the individual stress sessions was always at least four hours. Mice were returned in their 
home cages during the sedentary phases between stress episodes. Non-stressed (control) 
mice stayed in their cages, isolated from stressed mice, and were deprived of food and 
water according to the stress schedules. In the 9-week stress regime, all mice were left 
undisturbed for the final 24 hours before starting the m-RCT assay. 
Table 5. Comparison of the stress regimes involving repeated episodes of restraint 
Stress regime duration 24 hours 5-7 days 14 days 9 weeks 
Number of stress episodes 3 7-10 16 34 
Total amount of stress 9 h 14 h 20 h 40 h 
Duration of a restraint episode            2 h 1-2 h 1-2 h 30 min – 2h 
Duration of stress intervals 4-12 h 4-12 h 4-48 h 4-48 h 
Category repeated acute subchronic subchronic chronic 
 
To differentiate between the different regimes of the intermittent stress exposure applied 
in this thesis, the 24-hour regime is referred to as repeated acute stress, the 5-7-day and 2-
week regimes as subchronic, and the 9-week regime as chronic stress (Table 5). All mice 
were euthanized by isoflurane inhalation followed by cervical dislocation. The experiments 
were conducted in conformity with Finnish regulations, and the protocols were approved 
by the National Animal Experiment Board. Licenses can be found under the following diary 
numbers: ESAVI-2010-09327/Ym-23, ESLH-2009-06782/Ym-23 and 
ESAVI/6461/04.10.03/2011. 
2. The macrophage-to-feces RCT in vivo assay 
The method for measuring m-RCT in mice was applied as a shortened version in the acutely 
stressed and compound 48/80-treated mice (studies I and II) and as the conventional 24-48-
hour assay in the longer stress experiments (studies II and III). In brief, 
3
Hcholesterol 
(Perkin Elmer, Waltham, MA) -acetylated-LDL-loaded J774A mouse macrophages (ATCC, 
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Manassas, VA) or mouse primary peritoneal macrophages were injected into the peritoneal 
cavity, or in certain experiments under the skin of mice under light isoflurane anesthesia. To 
prevent coprophagy and to enable the collection of feces in the long assays, mice were 
housed in grid-bottom cages after the injections. The experiments were terminated at 3, 
24, or 48 hours after macrophage injection, and blood, liver, and intestine were removed. 
[
3
H]cholesterol radioactivity in serum HDL was determined by liquid scintillation counting 
after precipitation of apoB-lipoproteins with phosphotungstic acid and magnesium chloride. 
The luminal contents of the small and large intestines were collected by flushing with saline. 
Liver and fecal lipids were extracted with isopropyl alcohol-hexane (2:3). After 24 hours, the 
isopropanol and hexane layers were separated and the solvents were evaporated. 
Radioactivity was quantified by liquid scintillation counting separately from the hexane 
extracts (containing [
3
H]cholesterol) and from the isopropanol extracts (containing [
3
H]bile 
acids). The 
3
H-radioactivity in the samples was expressed as percentage of the injected 
dose.  
3. Pharmacological treatments of mice and staining of mast cells 
Table 6 lists the dosing parameters of the pharmacological treatments of mice that are 
referred to in this thesis.  
Table 6. Pharmacological treatments of mice 
Compound Study Dose (route) Vehicle 
Compound 48/80 I 0.5 and 1.0 mg/kg (i.p.) 0.9% NaCl 
Disodium cromoglycate - 100 mg/kg  (i.p.) 0.9% NaCl 
Ezetimibe II ~ 30 mg/kg/day (p.o.) Regular diet 
Corticosterone II 2 x 5 mg/kg (s.c.) 50% DMSO-saline  
Metyrapone II 100 mg/kg (i.p.)  10% DMSO-saline  
Human apoA-I I 3 mg/kg (i.p.) 0.9% NaCl 
DMSO=dimethyl sulfoxide. 
Compound 48/80 (Sigma, St. Louis, MO, USA) is a mixed polymer of p-methoxy-N-methyl 
phenylethylamine crosslinked by formaldehyde. It was used as an intraperitoneal injection 
to induce local mast cell degranulation. Cromolyn/disodium cromoglycate (Sigma) indirectly 
blocks calcium ions from entering mast cell, thereby preventing degranulation (Stenton et 
al. 1998). Mice were treated with cromolyn 30 minutes before restraint. In certain 
experiments, mice were fed for 10 days with a chow diet supplemented with a NPC1L1-
inhibitor ezetimibe (0.005% w/w, Teklad, Harlan Laboratories).  Corticosterone (Sigma) was 
administered twice, immediately before and at 1.5 h after the start of an m-RCT 
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measurement.  Metyrapone (Sigma), a reversible inhibitor of adrenal 11-beta-hydroxylase 
type I, was administered 90 minutes before the start of restraint.  
Mast cell staining was performed on 4-8-µm thick cryosections from the heart and skin of 
control and acutely stressed mice. The cryosections were stained with acidified 0.25% 
toluidine blue in 70% ethanol (pH 2.3) for 15 minutes in room temperature, washed 3 times 
and mounted for light microscopic examination.  
4. Analysis of serum, liver and feces of chronically stressed mice 
Serum was fractionated by FPLC size-exclusion chromatography on a Superose 6 column, 
and the lipoprotein elution profile was determined by measuring cholesterol and 
phospholipids in the eluted fractions. The ability of serum to generate preβ-HDL was 
assessed by 2-dimensional immunoelectrophoresis after incubating the serum for 6 hours 
at 37˚C with an LCAT inhibitor. Serum PLTP activity was recorded by measuring the transfer 
of [
14
C]phosphatidylcholine from radiolabeled vesicles to unlabeled HDL3 acceptors 
(Jauhiainen and Ehnholm 2005), and PON-1 was determined as described previously 
(Kleemola et al. 2002). Serum glucose levels were determined by an enzymatic glucose 
assay kit (Cayman Chemicals, MI, USA). Hepatic cholesterol concentration was measured 
(after lipid extraction) by the Amplex Red cholesterol assay kit (Thermo Fisher Scientific, 
Waltham, MA), and the expression of TNF-α was studied by RT-PCR. Fecal corticosterone 
and its metabolites were measured after ethanol extraction with an EIA kit validated for 
fecal samples (Cayman Chemicals).  
5. Statistical analysis 
GraphPad Prism software (La Jolla, CA) was used for all statistical analyses. The small group 
sizes posed certain limitations to the application of statistical methods. When data was 
normally distributed, student’s T-test was used to compare the control and stressed groups. 
The non-parametric Mann-Whitney test was used for data that did not follow Gaussian 
distribution or whenever a small size of a data set (N ≤ 5) did not allow the testing of 
normality. Probability values < 0.05 were considered statistically significant. One-way 
ANOVA or a non-parametric Kruskal Wallis test with Dunn’s post hoc test was applied for 
multiple comparisons. 
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V Results and discussion 
1. Mast cell activation may hinder the first step of m-RCT  
1.1 Mast cell activation blocks apoA-I-mediated stimulation of m-RCT (I) 
In recent years, the importance of the quality and functionality of circulating HDL for RCT 
and atheroprotection has been emphasized (Rothblat and Phillips 2010, Yamamoto et al. 
2011, Turner et al. 2012). The initial step of m-RCT which involves cholesterol efflux from 
macrophage foam cells to HDL is particularly sensitive to alterations in HDL quality. One 
factor potentially interfering with the first steps of m-RCT in the arterial wall might be the 
proteolysis of HDL particles by mast cell-derived enzymes. Previous work in our laboratory 
has demonstrated that the mast cell-secreted proteolytic enzyme chymase is able to cleave 
apoA-I, the main protein component of HDL particles (Lee et al. 2000). Accordingly, 
chymase-induced loss of apoA-I integrity perturbs the cholesterol acceptor capacity of 
reconstituted HDL particles which translates into diminished cholesterol efflux from 
macrophage foam cells in vitro (Lee et al. 2003a). Also mast cell activation in vivo disturbs 
the functionality of HDL: serum and peritoneal fluid derived from mice that are in 
anaphylactic shock, a state associated with systemic activation of mast cells, have 
diminished capacity to accept cholesterol from macrophage foam cells in vitro (Judström et 
al. 2010). To continue with this line of investigation, the effects of local mast cell activation 
on the complete m-RCT pathway were evaluated in mice. To this end, mast cell-activating 
compound 48/80, human apoA-I, a well-characterized stimulator of m-RCT (Cuchel et al. 
2006), and cholesterol-loaded macrophage foam cells were injected into the peritoneal 
cavity of mice. Since the full effects of preformed mast cell mediators, such as proteases, 
are exerted in less than 30 minutes after mast cell activation (Metcalfe et al. 1997), the 
delivery of macrophage-derived cholesterol into intestine was assessed at a short time scale 
(3 hours).  
Administration of the compound 48/80 completely blocked the stimulatory effect of human 
apoA-I on m-RCT (I: Figure 3). The effect was mast cell-dependent and attributed to loss of 
functionality of the injected apoA-I since treatment of apoA-I-injected mast cell-deficient 
SASH-mice, or mice injected with m-RCT-promoting phospholipid vesicles instead of apoA-I, 
with compound 48/80 did not reverse the induction of m-RCT (I: Figures 3 and 4). 
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Moreover, when two different doses of compound 48/80 (0.5 and 1.0 mg/kg) were injected 
into the mouse peritoneal cavity with human apoA-I, and the ability of peritoneal fluid to 
promote cholesterol efflux in vitro was assessed shortly thereafter, the extent of the 
ensuing reduction in cholesterol efflux was observed to be dose-dependent (I: Figure 2).  
1.2 Proteolysis hampers the cholesterol acceptor function of apoA-I (I) 
The peritoneal cavity of a mouse contains approximately 4 x 10
5
 to 7 x 10
5
 mast cells 
(Kolaczkowska et al. 2001, Morii et al. 2004). Although the number of lymphocytes and 
macrophages far exceeds the number of mast cells in the peritoneal cavity, because each 
mast cell is packed with granules containing preformed proteases, even partial activation of 
the peritoneal mast cell population is enough to markedly increase local protease activity. 
Two-dimensional immunoelectrophoretical analysis of the peritoneal fluid collected from 
the compound 48/80-treated mice revealed a drastic depletion of preβ-HDL, which suggests 
proteolytic degradation (I: Figure 5). The profile of native serum lipoproteins was not 
affected by the local mast cell activation (I: supplemental material). Importantly, the 
susceptibility of cholesterol acceptor particles to proteolysis varies: For example, apoA-I in 
small (9.6 nm) HDL particles is digested to a greater extent than apoA-I in larger (12.5 nm or 
17.0 nm) HDL particles (Kunitake et al. 1990, Lee et al. 2003a). It is thought that ApoA-I 
present in the small particles, such as the preβ-HDL, exists in a conformational state which 
increases its susceptibility to proteolysis (Kunitake et al. 1990, Lee et al. 2003a). It has been 
shown that mast cell -derived chymase preferentially targets the functional domains at the 
C-terminal region of the apoA-I (Phe
229
 and Tyr
192
 being the main cleavage sites, Usami et al. 
2012). Despite diligent searching, no proteolytic fragments of apoA-I were found in the 
peritoneal fluid after administrating compound 48/80 that could have confirmed the 
identity of the acting protease. The lack of fragments may be explained by rapid in vivo 
catabolism (Schmidt et al. 1995).  
Since chymases and tryptases are the most abundant mast cell proteases (Lutzelschwab et 
al. 1997, Tchougounova et al. 2003), they are the probable candidates for the observed 
proteolysis of preβ-HDL. Other proteases that have chymotrypsin-like cleavage specificity, 
such as cathepsin G, can be secreted by both mast cells and neutrophils. Activation of other 
peritoneal cells in addition to mast cells is also possible because there is no specific way to 
activate mast cells, and the compound 48/80 used in this study is known to activate sensory 
nerve endings which produce inflammatory mediators (Eglezos et al. 1992). To completely 
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assign the inhibition of m-RCT stimulation to mast cells, it would be necessary to compare 
the effects of compound 48/80 in SASH-mice with and without reconstituted mast cells. 
Furthermore, a specific KO-mouse model where chymase (the mouse mast cell protease 4) 
is lacking (Tchougounova et al. 2003) would have to be used to assign the proteolysis of 
apoA-I to chymase with complete certainty. 
However, the role of mast cell chymase in the in vivo degradation of apoA-I is highly 
probable as C-terminally truncated apoA-I molecules have been detected in human serum 
(Usami et al. 2012). Since interaction between the C-terminus of lipid-free apoA-I and 
ABCA1 is essential for the initial lipidation of apoA-I (Bodzioch et al. 1999, Alexander et al. 
2011), the first step of preβ-HDL formation was likely prevented in the compound 48/80-
treated mice. Thus, the observed depletion of preβ-HDL in the peritoneal cavity of 
compound 48/80-treated mice could be explained by simultaneous proteolysis of the 
injected apoA-I and prevention of the formation of lightly lipidated, preβ-migrating apoA-I 
particles. This would in turn explain the diminished cholesterol efflux from the injected 
foam cells and through that, the hampered apoA-I-mediated m-RCT in the compound 
48/80-treated mice. 
Although preβ-HDL is a supreme acceptor for macrophage cholesterol, it accounts for only 
about 5% of total apoA-I in normolipidemic human blood. However, in conditions such as 
hyperlipidemia and type 2 diabetes, the fraction of preβ-HDL may enlarge markedly at the 
expense of other circulating HDL subpopulations (Ishida et al. 1987). Moreover, preβ-HDL is 
the chief cholesterol acceptor in the lymph and interstitial fluids, such as intimal fluid of the 
arteries (Miller et al. 2013, Lim et al. 2013). Both normal and atherosclerotic arterial intimae 
contain about one mast cell for every 10 macrophages (Stary, 1990). The large secretory 
capacity of mast cells underlines their power; for example, it is estimated that the quantity 
of chymase in the human intimal fluid is equivalent to 0.6 μg/ml (Lindstedt et al. 2001), an 
amount that far exceeds the quantity that is needed to digest apoA-I in vitro. Therefore, 
local mast cell activation in the intima of arteries and the resulting depletion of preβ-HDL 
may pose detrimental consequences for cholesterol efflux from foam cells within the 
atherosclerotic lesions and fatty streaks, and explain in part the reported pro-atherogenic 
effect of vascular mast cell activation (Bot et al. 2007, Bot et al. 2011). 
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1.3 Stress as a physiological activator of mast cells (unpublished data) 
Because an increase in mast cell activation has been shown to occur in the skin (Singh et al. 
1999), heart (Huang et al. 2002), intestine (Santos et al. 2000, Vanuytsel et al. 2014), and 
urinary bladder (Spanos et al. 1997) of rodents that have been exposed to psychological 
stress or to isolated stress mediators, we tested if stress would be able to activate mast 
cells in a degree that would hamper the functionality of HDL in m-RCT. First, skin and heart 
samples were obtained from mice that were subjected to physical restraint stress for 3 
hours, a period of time that was established in Study I as long enough to allow the robust 
measurement of m-RCT. Cryosections were prepared and stained with toluidine blue, a dye 
that adheres to the sulfated glycosaminoglycans in mast cell granules (Markey et al. 1989). 
In agreement with the findings reported in literature, microscopical examination revealed 
an increase in the amount of degranulated mast cells in the skin of the stressed mice 
(control 33 ± 1% vs. stress 49 ± 2% degranulated, P = 0.02, n = 3-6 mice/group) and a non-
significant trend in the heart of the stressed mice (control 39 ± 11% vs. stress 55 ± 7% 
degranulated, P = 0.06, n = 4-8 mice/group). However, in sharp contrast to our 
expectations, a subsequent m-RCT in vivo analysis showed that the single 3-hour restraint 
episode promoted rather than inhibited m-RCT (II: Figure 1). This led us to conclude that, if 
stress-induced mast cell activation occurred in locations relevant for the m-RCT, i.e. the 
peritoneal cavity, liver or intestine, its effects on the functionality of HDL were too minor to 
be detected during m-RCT. The subsequent, extensive studies on stressed mice supported 
this notion by revealing that several steps of the m-RCT pathway were strongly affected by 
physiological mediators of stress. 
2. Psychological stress promotes m-RCT  
2.1 Endocrinological and metabolic effects of restraint stress (II, III, and unpublished 
data) 
In rodents, various experimental models have been applied to mimic psychological stress 
experienced by humans (Table 3). In the studies of this thesis, mice were exposed to only 
one type of stressor: physical restraint. The restraint stress procedure is believed to be 
largely psychological in nature due to the feeling of confinement. Altogether, one acute 
exposure and four different regimes of repeating stress ranging in duration from 24 hours 
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to 9 weeks were introduced (Table 4). During the 9-week stress regime, half of the mice 
were fed a western-type diet (WD) high in fat and cholesterol.  
When rodents are repeatedly exposed to a homotypic stressor for two weeks or more, they 
start to habituate to the stimulus due to adaptive mechanisms that aim at re-establishing 
homeostasis (de Boer et al. 1990, Keeney et al. 2006). To monitor the capacity of restraint 
stress to activate the HPA-axis, serum corticosterone was measured immediately after the 
final stress session applied in the stress regimes. In the case of the chronic stress groups, 
corticosterone metabolites were measured from fecal samples. As shown in Table 7, clearly 
elevated serum corticosterone levels were measured after the final stress episode in the 
subchronic stress regimes indicating lack of habituation (Studies II and III).  
Also metabolic data was gathered from stressed mice. A short hypoglycemic period typically 
follows acute stress because circulating glucose has been transiently directed towards 
oxidation in muscles (Frohman and Bernardis 1971). During repeated stress exposure, 
triglycerides become the preferred substrate for combustion, which translates into 
hypotriglyceridemia (Lam et al. 2007, Depke et al. 2008). In accordance with these notions, 
serum glucose and triglycerides were reduced after acute and subchronic stress, 
respectively (Table 7). 
Table 7. Comparison of the % change in serum corticosterone, triglycerides and glucose, and in body 
weight and food consumption in mice exposed to stress for 3 hours, 5 days or 14 days  
 Acute stress (3h)    Subchronic stress (5d)  Subchronic stress (14d) 
Serum corticosterone + 404%^ + 221%^               + 246%^ 
Body weight 
Serum glucose 
- 16%^ 
- 15%^ 
- 9.5%^ 
               - 15% 
                 ND 
                   ND 
Serum triglycerides 
Food consumption* 
             0% 
            None 
               - 15% 
               + 3% 
                 - 19%^                    
                   ND 
The data are derived from studies II and III. Values are presented as % change from the control mean. 
All serum parameters and body weights were measured immediately after the last stress session 
included in the regime. N = 10 - 15 mice/group. *Recorded per cage (5 mice per pool). ^Statistically 
significant difference (P < 0.05) to a respective control group. ND = not determined. 
 
Long-term exposure of rodents to stress typically triggers loss of body weight and appetite, 
effects that are induced by the stress-related secretion of leptin and glucagon (Frohman 
and Bernardis 1971, Depke et al. 2008, Rose et al. 2011). Accordingly, energy intake 
decreased in the WD-fed, chronically stressed mice (P=0.002), and trended downwards in 
the chow-fed, chronically stressed mice (P=0.06) when compared to the respective control 
groups (Table 8, unpublished data). All mice gained weight during the 9-week regime, but 
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the weight gain appeared to be attenuated in both of the chronically stressed mouse 
groups (statistically non-significant, P=0.06 and 0.09). When measured 72 hours after the 
final stress exposure and compared to the mean values of respective sedentary mouse 
groups, serum triglycerides or glucose levels were not altered in the chronically stressed 
mice (Table 8). 
Table 8. Effects of 9 weeks of chronic intermittent restraint stress on weight gain, energy intake, 
serum glucose and triglycerides in chow- and WD-fed mice 
        Chow diet (n=10)                Western diet (n=10) 
Control    Stress         Control        Stress 
Total weight gain (% of BW) 
Energy intake (kcal/5 mice/w) 
  12 ± 2 
277 ± 8  
     8 ± 2 
 254 ± 7 
         52 ± 7^ 
       404 ± 12^ 
      38 ± 4^ 
    344 ± 10^ 
Serum glucose (mg/dl)* 
Serum triglycerides (mmol/l)* 
216 ± 13 
 0.6 ± 0.04 
 268 ± 24 
  0.6 ± 0.05 
       265 ± 8 
        0.7 ± 0.05^ 
    310 ± 31^ 
     0.8 ± 0.06^ 
Values are presented as mean ± standard deviation. * Serum was collected from non-fasted mice 72 h 
after the last stress session at week 9. ^P < 0.05 when compared to the chow-fed control group.  
  
Measurement of fecal corticosterone metabolite excretion is a powerful, non-invasive tool 
to monitor adrenocortical activity in laboratory mice (Touma et al. 2004). When compared 
to the pooled samples from non-stressed mice, fecal sample pools from chow-fed mice 
exposed to chronic stress contained higher concentrations of corticosterone metabolites 
throughout the experiment (Figure 5, unpublished data). Intriguingly, WD-feeding alone 
resulted in elevated excretion of corticosterone metabolites in the non-stressed mice. This 
may be explained by the intrinsic ability of the high-fat diet to augment both basal and 
stress-induced ACTH and glucocorticoid excretion, a notion that has prompted researchers 
to categorize high-fat feeding as a stressor per se (Pascoe et al. 1991, Tannenbaum et al. 
1997, van der Sluis et al. 2012). The finding could have implication also in humans as 
chronic stress commonly stimulates the consumption of energy-dense foods (Tryon et al. 
2013) which might create a feed-forward loop. 
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Figure 5. Fecal corticosterone metabolite 
(CM) excretion in control and stressed mice 
during 9 weeks. The fecal samples were 
collected from cages at weeks 1, 4, and 9 and 
were oven-dried. Data points represent pools 
from 5 mice per group. The results are 
expressed as nanograms of CM excreted per 
gram of feces produced and normalized to 
group average bodyweight (BW) at the 
collection weeks. Two of the groups were fed 
with normal chow (black lines) and two 
groups with a western diet (WD, gray lines). 
Altogether, the restraint stress regimes applied in this thesis induced corticosterone 
secretion (in all regimes), accompanied with characteristic changes in serum glucose and 
triglycerides (in acute and subchronic stress), and food consumption and body weight (in 
chronic stress), which demonstrate the stress-inducing potential of the treatments. Lack of 
evident habituation may be explained by the relatively low frequency of stress exposure 
within the subchronic and chronic stress regimes which allowed mice (and their HPA-axis) 
to recover from individual stress episodes. 
2.2 Stress does not interfere with the first step of m-RCT (II and III) 
When mice were challenged with acute stress, serum cholesterol plummeted after the first 
10 minutes and did not completely return to control level during the following three hours 
(II: supplemental material). A modest increase in the hepatic protein expression of the 
cholesterol uptake receptor SR-BI was observed in stressed mice (II: supplemental material) 
which could provide one explanation for the transiently reduced serum cholesterol levels. 
Importantly, non-stressed corticosterone-treated mice did not exhibit any changes in serum 
cholesterol levels (II: supplemental material). This, together with the fact that a majority of 
the effects of glucocorticoids are genomic and are therefore exerted hours after the onset 
of the stressor, suggest that the initial, fast, stress-related decrease in serum cholesterol 
was SNS- rather than corticosterone-mediated.  
Also mice subjected to subchronic stress exhibited an initial decrease in serum total 
cholesterol that was no more evident when assessed four hours after stress. Interestingly, 
the reduction in serum cholesterol was emphasized in the non-HDL fraction (III: Table 1) 
which mainly comprises of VLDL in mice (Dietschy and Turley, 2002). Activation of PPARα, 
which directs hepatic fatty acids into β-oxidation, may have contributed to this reduction by 
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lowering the levels of triglycerides that are available for VLDL production (Table 7 and III: 
Table 1). 
Serum cholesterol and HDL levels can vary over a wide range without any effect on m-RCT, 
demonstrating that the rate of cholesterol efflux from macrophages is more relevant for m-
RCT than the steady-state serum lipid levels (Rothblat and Phillips 2010). The ex vivo 
cholesterol efflux to serum that was obtained from mice subjected to acute or subchronic 
stress was as efficient as the efflux promoted by control mouse serum (II: Figure 2A; III: 
Figure 3). Also serum LCAT activity, apoA-I levels, and the average size distribution of HDL 
particles were similar between acutely stressed mice and sedentary controls (II: 
supplemental material). Neither were there any changes in the mRNA expression of the 
cholesterol efflux transporters ABCA1, ABCG1, and SR-BI in corticosterone-treated J774A 
foam cells (II: Figure 4). This indirect evidence implies that the observed reduction in serum 
total cholesterol levels was not associated with alterations in the overall quality or 
functionality of HDL in stressed mice. 
2.3 The intestine is a major target of stress (II, III, and unpublished data) 
Besides the function of the gut as a regulatory organ capable of absorbing and secreting 
cholesterol and bile acids, recent developments have established its role in exerting 
systemic effects that modulate the m-RCT rate (Lee-Rueckert et al. 2013). The intestine is 
highly innervated and sensitive to several hormonal mediators activated in stress. In effect, 
psychological stress alters ion transport, epithelial permeability, and mucin production in 
the small and large intestinal mucosa (Santos et al. 2000, Ferrier et al. 2003) and regulates 
peristalsis along the whole organ (Lenz et al. 1988b). In this light, it is not surprising that 
major changes in m-RCT induced by restraint stress were due to modulation of the pathway 
at the intestinal level.  
2.3.1 Cholesterol absorption  
PPARα functions as a fatty acid sensor that controls the catabolism and storage of fatty 
acids in several tissues. Activation of hepatic PPARα is a typical finding in stressed animals, 
and it is thought to occur due to both increased circulating fatty acid levels and direct 
stimulation by stress hormones (Konstandi et al. 2013). Increased transcription of intestinal 
PPARα is less typical although it has also been described (Sato et al. 2006). The activation 
mechanism of intestinal PPARα can be assumed to be similar to that of hepatic PPARα. In 
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our mouse model, intestinal Pparα was strongly induced by acute (II: Figure 4), repeated 
acute (unpublished data, not shown), and subchronic stress (III: Figure 4).  
Downregulation of the intestinal cholesterol transporter Npc1l1 paralleled the induction of 
intestinal Pparα after exposure to both acute and subchronic stress (II: Figure 4, III: Figure 
4). Upon acute stress, the reduction in NPC1L1 transcription associated with reduced 
cholesterol absorption (II: Figure 2C) which eventually promoted fecal excretion of 
macrophage-derived cholesterol (II:  Figure 1C). This interpretation is supported by the fact 
that treatment of the mice with the NPC1L1-inhibitor ezetimibe also promoted m-RCT and 
stress did not have an additional effect on top of this (II: Figure 3). Ezetimibe is thought to 
function by preventing the internalization of cholesterol-NPC1L1-complexes from the cell 
membrane, although the exact mechanism is still under debate. Ezetimibe is used clinically, 
alone or in combination with statins, to treat patients with dyslipidemia to lower the risk of 
atherosclerosis. Detailed studies have shown that ezetimibe induces doubling of the flux of 
plasma-derived cholesterol into fecal neutral sterols in humans (Davidson et al. 2013). 
Inactivating mutations in NPC1L1 associate epidemiologically with low serum LDL levels and 
53% lower risk of coronary heart disease (Stitziel et al. 2015) which further demonstrates 
the universal importance of NPC1L1-mediated cholesterol absorption for RCT. 
Since acute stress exposure did not stimulate m-RCT or reduce NPC1L1 mRNA expression in 
mice lacking PPARα (II: Figure 8 and supplemental material), the reduction of cholesterol 
absorption was evidently accounted to PPARα and not to other PPAR isoforms. The stress-
induced upregulation of PPARα (Lemberger et al. 1996) and PPARα-agonism-induced 
NPC1L1 downregulation (Valasek et al. 2007, de Vogel-van den Bosch et al. 2008) have been 
independently reported in previous mouse studies, but Study II was the first to show the 
complete sequence of events to occur upon acute stress exposure. The apparent purpose of 
the cholesterol malabsorption triggered by acute stress remains elusive. There are a few 
reports of decreased glucose (Shepherd et al. 2004) and oleic acid (Yau et al. 1971) 
absorption during stress in animal models. Moreover, activation of intestinal PPARα by a 
synthetic agonist has been reported to repress the expression of glucose and amino acid 
uptake transporters in the mouse intestine (de Vogel-van den Bosch et al. 2008). These 
reports suggest that the absorptive functions of the gut may be compromised during stress 
and support the interpretation that the stress-induced reduction in cholesterol absorption 
might have been a “side effect” of the drastic induction of PPARα in the intestine.  
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Ultimately, the functional reduction in cholesterol absorption was transient as fecal 
cholesterol excretion started to normalize already during a 24-hour period involving three 
stress episodes (Table 9, partly unpublished data). Intriguingly, the normalization of 
cholesterol absorption occurred without attenuation of the PPARα-induced downregulation 
of Npc1l1 (III: Figure 4). Possible mechanisms that might have rescued cholesterol 
absorption in repeatedly stressed mice involve downregulation of the intestinal cholesterol 
transporter Abcg5/8 (III: Figure 4) and changes in the post-translational regulation of 
NPC1L1. Since the intestinal NPC1L1 and ABCG5/8 transport cholesterol in opposite 
directions (Table 1), suppression of the Abcg5/8 could decrease the re-excretion of 
absorbed cholesterol back into the intestinal lumen so helping in returning cholesterol 
absorption rate to a normal level during Npc1l1 downregulation. Accordingly, it has been 
proposed that the NPC1L1-mediated cholesterol influx into enterocytes (which provides 
substrates for oxysterol synthesis) is necessary for LXRα-mediated activation of ABCG5/8 at 
the protein level (Kannisto et al. 2014). An alternative explanation for the preserved 
cholesterol absorption rates during Npc1l1 downregulation is an adaptive change in the 
endocytic recycling of NPC1L1 which might have promoted NPC1L1 activity at the 
enterocyte brush border (Skov et al. 2011). 
Table 9. Comparison of changes in cholesterol absorption in mice exposed to stress regimes of 
different durations 
Type of stress regime 
 (duration of the regime) 
        Acute  
         (3h) 
    Repeated acute  
            (24h) 
Subchronic  
     (5d) 
Total stress exposure          1 x 3 h            3 x 3 h             7 x 2 h 
Cholesterol absorption       - 18.4%^*          - 10.8%             + 7.9% 
Serum [
14
C]cholesterol ~       - 54.5%^           - 3.5%             + 15.3% 
The data are partly derived from Studies II and III. Cholesterol absorption was measured by the fecal 
dual isotope method, and values are presented as % change from the control mean. ~Serum level of 
dosed [
14
C]cholesterol was recorded three hours (acute stress) or 24 hours (repeated and subchronic 
stress) after an oral gavage. *The 3-hour cholesterol absorption is calculated based on [
14
C]cholesterol 
and [
3
H]sitostanol levels in feces collected only over three hours. This does not allow the 
determination of total cholesterol absorption; thus the data are not directly comparable with 
fractional cholesterol absorption measured over 24 hours in the repeated acute and subchronic 
settings (indicated by the double line between columns). ^Statistically significant difference (P < 0.05) 
to a corresponding non-stressed mouse group. N= 5-10 mice/group.  
 
2.3.2 The enterohepatic circulation of bile acids  
Stress-induced SNS and CRH secretion activate enteric motor neurons that induce smooth 
muscle contractions in the distal intestine and sedate the motor function in the stomach 
and small intestine (Lenz et al. 1988a). In our model, acute stress drastically stimulated 
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transit in the large intestine, while its effects on gastric and small intestinal emptying were 
minor (II: supplemental material). This supports the conclusion that cholesterol absorption, 
which occurs in the small intestine, was reduced through a transporter-mediated 
mechanism in acutely stressed mice.  
Mice exposed to subchronic stress (1-2 times/day for 5 days, or once a day for 14 days) also 
exhibited stress-triggered colonic emptying up to the end of the stress regime (III: Figure 4 
and data not shown). Notably, when mice were exposed to more than one stress episode 
per day, the transient increases in colonic motility induced a cumulative increase in fecal 
bile acid excretion (III: Figure 5) which translated into stimulated m-RCT (III: Figure 3). The 
mRNA expression of transporters responsible for active bile acid absorption in the ileum 
(ASBT, ILBP, OSTα/β) was not changed in repeatedly stressed mice (III: Figure 6). This 
suggests that the majority of the bile acids that were lost in feces were probably secondary 
bile acid species and other unconjugated and uncharged bile acids that are normally 
absorbed passively in the large intestine. Gas-liquid chromatography analysis of the fecal 
bile acid pool composition did not reveal any significant alterations in the ratio of fecal 
primary and secondary bile acids between control and stressed mice (III: Figure 5). 
However, as the amount of unidentified bile acid species in the mouse feces was large, this 
result does not completely exclude alterations in the bile acid pool composition. 
The pattern of colonic motor responses to stress is relevant also in human physiology. 
Various experimentally induced and naturally occurring stressors, such as fear, anxiety, and 
stressful interviews increase colonic motility in healthy subjects (Rao et al. 1998). Stress also 
worsens the symptoms of inflammatory bowel disorders that are characterized by 
disturbed intestinal motility, diarrhea and bile acid malabsorption (Wong et al. 2012). Thus, 
stress-induced fecal bile acid loss might occur also in humans. Bile acid sequesterants are 
large polymeric compounds that bind ionized bile acids in the gut and so can be used to 
relieve symptoms associated with bile acid malabsorption. Since bile acid sequesterization 
in the gut induces hepatic bile acid synthesis, which in turn lowers LDL-cholesterol levels in 
humans, bile acid-binding resins were among the first drugs that were used to treat 
hyperlipidemia (Hashim and Vanitallie, 1965). 
When exposed to subchronic stress, mice exhibited modest depletion of gallbladder and 
serum bile acids (III: Figure 7 and Table 1) as well as downregulation of the hepatic Fxr and 
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its target genes Bsep and Fgf15 (III: Figure 6), all of which presumably resulted from the 
increased loss of bile acids in feces. Because the circulating and biliary bile acid levels 
normalized in just four hours after stress (III: Figure 7 and Table 1), a compensatory 
increase in de novo bile acid synthesis or in intestinal absorption likely occurred. The latter 
is supported by the findings according to which ASBT is stimulated by glucocorticoid 
administration in rabbits (Coon et al. 2010) and mice (Out et al. 2014). However, since 
neither the hepatic CYP7A1, the rate limiting enzyme of the major bile acid synthesis 
pathway, nor the intestinal ASBT, were upregulated when assessed four hours after stress 
exposure (III: Figures 6 and 7), the recovery mechanism of the bile acid levels remains 
elusive.  
The lack of Cyp7a1 induction by the downregulated Fxr and Fgf15 is surprising considering 
the efficiency of the feedback regulation controlling the bile acid pool size (Holt et al. 2003, 
Kok et al. 2003). Naturally, without actually measuring the rate of bile acid synthesis in the 
liver of the stressed mice, the lack of CYP7A1 induction (or the activation of the alternative 
bile acid synthesis pathways) cannot be completely confirmed. Since the cannulation of the 
mouse bile duct is technically challenging, and would have been difficult to apply during the 
stress regimes, we have no data of possible alterations in bile flow during stress that could 
help explain the observed changes in gallbladder bile acid content (Out et al. 2014). 
Nevertheless, two mouse studies applying very similar stress models to ours reported 
increased transcription of Cyp8b1 but not of Cyp7a1 (Konstandi et al. 2013, Depke et al. 
2008). Apart from an opposite result on Cyp8b1 (III: Figure 6), our data are in line with 
these studies. This suggests that additional mechanisms affecting CYP7A1 may be activated 
in stress, a possibility that is discussed further in the following section (2.4).   
Altogether, the mechanism of m-RCT stimulation in acute and subchronic stress was 
different, at least regarding intestinal cholesterol absorption (Table 9). Apart from 
measuring the mRNA expression of hepatic ABCG5/8, which was not altered (II: Figure 4), 
biliary trafficking of cholesterol and bile acids was not studied during acute stress; therefore 
possible changes in bile acid homeostasis that might have influenced m-RCT in this setting 
remain unknown. Intriguingly, according to our unpublished data, cholesterol concentration 
in the gallbladder bile of acutely stressed mice was increased (control 3.3 mmol/l vs. stress 
4.8 mmol/l, P < 0.01, N = 6). The volume of the gallbladder bile and its phospholipid and bile 
acid concentrations remained unchanged (data not shown). Since the decrease in 
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cholesterol absorption did not trigger an immediate increase in hepatic or intestinal 
cholesterol synthesis in these mice (II: supplemental material), the source of the additional 
gallbladder cholesterol was probably serum HDL. This is in agreement with the increased 
protein expression of the hepatic SR-BI and promoted clearance of serum HDL observed in 
the acutely stressed mice (II: supplemental material). 
2.4 Crosstalk between nuclear hormone receptors in stress (II and III) 
During the course of our studies, complex interplay between several members of the 
nuclear receptor superfamily of ligand-activated transcription factors became evident. 
Table 2 summarizes the known effects of the activation of crucial nuclear receptors on m-
RCT in mice.  
As described above, intestinal Pparα was strongly stimulated by stress exposure. Although 
the protein levels of PPARα or expression of its classical target genes such as carnitine 
palmitoyltransferases (Kliewer et al. 1994) were not analyzed, the upregulation of the gene 
seemed robust since it occurred in all of our acute and subchronic stress models. The mRNA 
levels of LXRα decreased in the liver of mice that were exposed to subchronic stress (III: 
Figure 4), suggesting that also this transcription factor may be directly or indirectly affected 
by stress. There are no reports in the literature of a direct effect of glucocorticoids on LXRα 
outside the adrenal glands where cholesterol acts as a precursor of glucocorticoids 
(Cummins et al. 2006). Instead, there are a few studies showing that LXRα is able to 
suppress the functions of the GR (Stulnig et al. 2002, Steffensen et al. 2004, Nader et al. 
2012). Importantly, PPARα and LXRα appeared to cooperate in the stimulation of m-RCT 
during acute stress because short-term exposure of LXRα-KO mice to stress did not induce 
changes in the fecal excretion of macrophage-derived cholesterol (II: Figure 8), a finding 
supported by studies of others (Nakaya et al. 2011). However, the result must be 
interpreted with caution since the nature of the relationship between the two transcription 
factors is not completely clear: When mice are treated chronically with a PPARα agonist, 
intestinal NPC1L1 expression can be repressed independent of LXRα and LXRβ (Valasek et 
al. 2007). According to another study, also LXRα might be able to independently 
downregulate NPC1L1 (Duval et al. 2006). Since both PPARα and LXRα are capable of 
regulating several steps of the m-RCT pathway (Table 2), and since these two nuclear 
factors may also regulate each other at the intestinal level (Colin et al. 2008), dissecting 
their independent effects is rather difficult. 
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Another example of the interplay between LXRα, PPARα, and FXR is illustrated in the 
regulation of hepatic CYP7A1: the transcription of this key enzyme is directly and indirectly 
suppressed by FXR and PPARα, and stimulated by LXRα (Peet et al. 1998, Post et al. 2001, 
Kok et al. 2003, Li et al. 2012a). Both Lxrα and Fxr were downregulated in mice that were 
subjected to subchronic stress. Although FXR downregulation should boost bile acid 
production (Kok et al. 2003), possible stress-induced induction in PPARα activity and the 
observed inhibition of Lxrα might have produced an FXR-independent impeding effect on 
CYP7A1 activity upon stress exposure.  
The complex nuclear hormone activation pattern in stress may serve to protect the body 
from overshoot of GR-induced changes. For example, by stimulating fatty acid oxidation, 
PPARα protects the liver from toxic accumulation of lipids. Hepatic LXRα, on the other hand, 
is a negative regulator of gluconeogenesis and a stimulator of bile acid synthesis and thus, it 
may also protect the liver from steatosis by locally counteracting the effects of 
glucocorticoids and catecholamines (Stulnig et al. 2002). This may be analogous to the 
function of LXRα in the adrenal gland where it maintains appropriate levels of free 
cholesterol by regulating the expression of ABCA1 and the steroidogenic acute regulatory 
protein (Cummins et al. 2006). In the intestine, PPARα-induced oxidation of ketone bodies 
and stimulation of genes that mediate defense against oxidative stress are believed to 
protect the epithelium from stress-induced injuries (Sato et al. 2006, Mazzon et al. 2009, de 
Vogel-van den Bosch et al. 2008).  
An important issue to note is the species-specific regulatory pattern of the nuclear 
receptors and their downstream target genes. In accordance to our results, PPARα 
activation has been shown to promote m-RCT in various rodent models (Berthou et al. 
1996, Mukherjee et al. 2008, Nakaya et al. 2011). However, this result is difficult to 
translate into the human situation due to crucial differences in PPARα target genes. 
Amphipathic carboxylic acids called fibrates are clinically used as PPARα activators in 
humans to lower triglyceride levels in patients with metabolic syndrome. Fibrates also 
decrease the number of coronary events (Frick et al. 1997) probably via their LDL-lowering 
and HDL-elevating effects (Staels et al. 1998). PPARα stimulates the expression of ABCA1 in 
human macrophages (Chinetti et al. 2001) and induces apoA-I production in the liver and 
intestine which could explain the elevation in the levels of circulating HDL. Interestingly, this 
effect of PPARα is completely lacking in mice (Berthou et al. 1996, Nakaya et al. 2011). 
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Whether PPARα could affect NPC1L1 in humans, and if this would be part of the 
cardioprotective mechanism of fibrates, is not known. Importantly, the human NPC1L1 
gene is expressed not only in the intestine but also in the liver where it negatively regulates 
biliary deposition of cholesterol and RCT (Altmann et al. 2004, Temel et al. 2010). If also 
hepatic NPC1L1 was to be negatively regulated by PPARα, it could cancel out the effects of 
the inhibition of intestinal NPC1L1. 
2.5 The effects of chronic stress on m-RCT (unpublished data) 
To assess the long-term effects of stress on cholesterol homeostasis, m-RCT and serum 
lipids were assessed in mice that were stressed intermittently for 9 weeks and fed normal 
chow or a western-type diet. After the 9-week regime, the rate of the transfer of 
macrophage cholesterol into feces over 24 hours was similar in non-stressed and stressed 
mice (Figure 5, unpublished data). Neither were the serum cholesterol or apoA-I levels 
altered when measured 72 hours after the final stress exposure of the regime (Table 10, 
unpublished data). In line with the results reported by Escola-Gil et al (2011), the WD 
strongly promoted m-RCT (P < 0.01, N = 5). Previous studies propose elevated biliary 
cholesterol secretion through the hepatic ABCG5/8 transporter as the main mechanism 
promoting m-RCT in WD-fed mice (Hayek et al. 1993, Escola-Gil et al. 2011). Accordingly, we 
observed a drastic increase in fecal [
3
H]cholesterol excretion whereas the fecal excretion of 
[
3
H]bile acids was similar in all groups of mice (Figure 6). Since the WD also resulted in 
notably elevated serum HDL levels, which was reflected by increases in apoA-I and the HDL-
resident antioxidant enzyme PON-1 (P<0.01 for all, Table 10), pre-hepatic steps of m-RCT 
might also have been stimulated in the WD-fed mice. 
 
 
 
Figure 6. Transfer of [
3
H]cholesterol from the 
peritoneal cavity into feces was measured 
over 48 hours, starting at 24 hours after the 
final stress exposure of the 9-week chronic 
stress regime. Two mouse groups were fed 
normal chow and two groups were fed with a 
western diet (dashed bars). Fecal 
3
H-
radioactivity (as % of injected dose) was 
measured from the nonpolar (cholesterol) 
and polar (bile acids) phases of the extraction 
mixture. Data are presented as mean + SD. N 
= 5 mice/group. 
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Table 10. Effects of chronic stress on cholesterol and apoA-I levels in serum, PLTP and PON-1 activities 
in serum and Tnf-α transcription in the liver of chow- and WD-fed mice 
          Chow diet (n=10)        Western diet (n=10) 
   Control  Stress   Control       Stress 
Serum total CHOL (mmol/l) 
Serum HDL (mmol/l) 
  2.2 ± 0.06 
  1.8 ± 0.07 
  2.0 ± 0.03 
  1.6 ± 0.12 
4.0 ± 0.23** 
3.1 ± 0.26** 
   4.3 ± 0.14** 
   3.4 ± 0.16** 
Serum apoA-I (mg/ml) 
Serum preβ generation 
Serum PLTP (µmol/ml/h) 
Serum PON-1 (µmol/min) 
Liver total cholesterol (mg/g) 
Liver Tnf-α expression (AU)~ 
  1.4 ± 0.05   
   46 ± 8 
   36 ± 3 
   75 ± 7 
  7.9 ± 0.2    
  1.0 ± 0.2 
  1.1 ± 0.02 
   30 ± 8 
   29 ± 3 
   76 ± 7 
  8.6 ± 0.3 
  0.5 ± 0.2* 
1.9 ± 0.13* 
 18 ± 3** 
 43 ± 7 
 99 ± 8* 
8.3 ± 0.7 
      ND 
   1.7 ± 0.04*  
    16 ± 5** 
    44 ± 2 
  100 ± 5* 
   8.5 ± 0.7 
        ND 
Data are presented as mean ± SD. CHOL = cholesterol, HDL = high density lipoprotein, PLTP = 
phospholipid transfer protein, PON-1 = paraoxygenase 1. ND = not determined. ~Tnf-α expression was 
studied by RT-PCR and normalized to Gadph expression (N=5). *P < 0.05, **P < 0.01 when compared 
to the non-stressed, chow-fed group (1. column). 
 
The rationale for combining the WD with chronic stress was to challenge the metabolic 
control of energy and cholesterol homeostasis by the diet to uncover possible synergistic 
and/or opposing effects between stress and dietary cholesterol overload. The 
measurement of serum parameters 72 hours after the final stress session of the regime 
enabled the identification of long-term changes. As shown in the Table 8, despite the 
corticosterone secretion-inducing effect of the WD (Figure 5), of the measured parameters, 
only serum glucose showed a long-term synergistic response between chronic stress and 
the WD. This is in agreement with the established role of stress in aggravating the glucose 
intolerance associated to metabolic syndrome (Bergmann et al. 2014). 
The low amount of stress exposure (4 hours/week) in the experiment could be considered a 
weakness. In the light of the results shown in Figure 6 and Table 10 it seems that the 
amount of stress in this long study was probably too low to induce changes in the whole-
body cholesterol balance. However, the sensitivity of different systems to stress mediators 
varies. Glucocorticoids affect the immune system by regulating gene expression and the 
migration, death, and survival of all immune cells (Sapolsky et al. 2000). The chosen 
intensity of stress was enough to induce a reduction in hepatic transcription of the 
inflammatory marker Tnf-α (Table 10), a cytokine that is suppressed by IL-6 secretion during 
acute stress in mice (Nukina et al. 1998). Furthermore, chronic exposure to stress typically 
triggers habituation or, in some cases, dysregulation of the stress-sensitive brain areas 
(Datson et al. 2013). In our model, the low frequency of restraint sessions probably helped 
in keeping the HPA axis responsive to the stressor (Figure 5). An alternating pattern of 
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stressors would have to be applied if the amount of stress was to be increased without 
habituation in this kind of an experimental setting.  
Altogether, the mild, chronic intermittent stress regime did not induce long-lasting changes 
in m-RCT. Neither did chronic stress exposure modify the outcome of m-RCT stimulation 
induced by a cholesterol-rich diet. However, serum glucose level was clearly elevated in 
mice that received both stress and the WD, suggesting that regulation of the glucose and 
insulin balance (Kuo et al. 2007) was disrupted during the combination treatment.  
3. Mediators of stress and suggestions for future studies  
3.1 Molecular mediators of stress (II) 
Stress harbors an array of mediators. In Study II, the effects of acute stress on Pparα, 
NPC1L1 and m-RCT could be mimicked by mere administration of the stress hormone 
corticosterone (II: Figure 5 and 7, and supplemental material). Conversely, inhibition of 
corticosterone (and aldosterone) synthesis by administration of the adrenal 11-beta-
hydroxylase inhibitor metyrapone prior to acute stress inhibited the stimulation of m-RCT 
(II: Figure 6). These results point towards corticosterone as a central mediator of the effects 
of acute stress on m-RCT, although it must be noted that distinct differences in the 
responses of the intestinal cholesterol transporters to stress and corticosterone treatment 
appeared (II: Figure 4 and 7). 
From the plethora of neurohormonal mediators that are activated in stress, in addition to 
corticosterone, only the secretion of CRH, the hypothalamic hormone responsible for the 
stimulation of pituitary ATCH and adrenal corticosterone secretion, was investigated. CRH 
peaked during the first 10 minutes of restraint and returned to control levels fast thereafter 
(II: supplemental material). This, together with the marked reduction in CRH observed in 
corticosterone-treated mice (II: supplemental material), reflects a fast negative feedback 
inhibition of the stress axis and suggests that systemic CRH did not play a significant role in 
the modulation of m-RCT or NPC1L1 expression in acutely stressed mice.  
The pattern of neurohormonal activation during repeated stress is presumably more 
complicated than during acute stress. In chronic stress, the receptors of CRH (mainly CRH-2) 
bind also other mediators such as urocortins, which are structurally related to CRH. The 
urocortins 1, 2 and 3 induce enduring changes in gut motility (Martinez et al. 2004) and 
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participate in the control of the stress recovery phases and appetite during chronic stress 
(Neufeld-Cohen et al. 2010). This makes urocortins potential mediators of the (intestinal) 
effects of subchronic stress (Study III) and interesting stress mediators the role of which 
should be further investigated especially in chronic stress situations. 
Finally, due to the complexity of the m-RCT pathway as a whole and the vast number of 
molecules, including the newly discovered microRNAs (Rayner et al. 2011, Allen et al. 2012), 
that participate in its regulation, several important topics remain for future research. For 
example, m-RCT can be promoted via increased TICE (Kruit et al. 2005, van der Velde et al. 
2008, Temel et al. 2010, Le May et al. 2013). This alternative route of cholesterol transport 
into the intestine cannot be dissected from biliary cholesterol flux in the m-RCT assay and 
therefore the contribution of TICE to the stress-dependent m-RCT induction remains 
unknown.  
3.2 Mast cells (I and unpublished data) 
As described, acute restraint stress exposure activated mast cells in the skin of mice. The 
fact that the baseline rate of m-RCT, or the native lipoproteins in mouse serum, were not 
affected by local mast cell activation (I: supplemental material) does not rule out all 
contributions of stress-activated mast cells to individual components of the m-RCT 
pathway. Therefore, in two small experiments, mast cell-deficient female SASH-mice, and 
female C57Bl/6J mice that were pretreated with the mast cell stabilizer disodium 
cromoglycate (cromolyn), were exposed to acute stress. According to our unpublished data, 
the stressed mice in these two experiments did not show elevated m-RCT during the 3-hour 
assay [normalized intestinal 3H-radioactivity 1.0 ± 0.66 in the control group (n=9) vs. 0.60 ± 
0.57 in stressed SASH-mice (n= 6, P=0.17) and 1.06 ± 0.56 in stressed, cromolyn-pretreated 
mice (n=4, P=0.82)]. This could indicate a role for mast cells in the stimulation of m-RCT. 
The results must however be interpreted with caution because cromolyn may excert 
pleiotropic effects on other immune cells (Storms and Kalinger 2005) and, since no litter-
mate controls were available for the SASH-mice, an interference by the modest 
gastrointestinal abnormalities that SASH-mice exhibit (Grimbaldeston et al. 2005) cannot be 
ruled out. 
The result is nevertheless interesting and highlights the diversity of mast cell mediators and 
targets. The m-RCT-modulating potential of mast cells may depend on their location: while 
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mast cell activation in the arterial intima hampers cholesterol efflux from macrophages (Bot 
et al. 2007, Bot et al. 2011), mast cell activation in the skin promotes RCT locally by 
increasing vascular permeability (Kareinen et al. 2014). Because intestinal mast cells are 
efficiently activated by CRH (Overman et al. 2012) and may be affected also by other 
neuropeptides released during stress, their contribution to modulation of m-RCT in our 
experimental model is possible. For instance, since the mast cell proteases are able to 
modify tight junctions and the extracellular matrix they could have altered the functions of 
enterocytes at the intestinal lining. Accordingly, an intestinal mucosal inflammatory 
response that involves mast cells and may interfere with the absorption functions of 
enterocytes has been described in dexamethasone-treated mice (Haikonen and Räsänen 
1963). Further studies are needed to unravel the role of mast cells in the regulation of m-
RCT as it is relevant to atherosclerosis. 
4. Methodological considerations 
4.1 The choice of animal model 
Since reconstruction of the complete m-RCT pathway is not possible in in vitro-models, 
most of our studies were executed in experimental animals. The mouse is a feasible model 
for studying whole-body cholesterol trafficking; it hosts all the major cholesterol and bile 
acid transporter proteins and regulatory molecules that are expressed in humans. Naturally, 
there are also limitations, some of which have been discussed in conjunction to the specific 
topics. The key differences in the whole-body cholesterol homeostasis between mice and 
humans are highlighted in Table 11.  
Table 11. Cholesterol turnover in the mouse and the human 
 Mouse Human 
Whole-body cholesterol pool (mg/kg) 2200  2200 
Contribution of hepatic synthesis (% to total pool) 40 10 
Steady state LDL-cholesterol level in blood (mM) 0.2 3 
Steady state HDL-cholesterol level in blood (mM) 2 1.2 
Fecal cholesterol excretion (mg/day/kg) 60 8 
Fecal bile acid excretion (mg/day/kg) 50 7 
Adapted from Dietschy and Turley (2002). 
Due to their overall faster metabolism, mice exhibit high rates of hepatic cholesterol 
synthesis and of fecal cholesterol and bile acid excretion. The steady state concentrations of 
circulating VLDL and LDL are lower in mice than in humans (Table 11). Several “humanized” 
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mouse models which exhibit more atherogenic blood lipid profiles are available (Plump et 
al. 1992, van den Maagdenberg et al. 1993). However, because the regulation of m-RCT 
might be distorted in these genetic models (Zanotti et al. 2011), and because studying the 
actual atherosclerotic lesion formation was beyond the scope of this study, our studies 
were based on the wild-type C57Bl/6J mouse. This strain exhibits only mild fatty streak 
formation upon long-term high fat - high cholesterol diet (Nishina et al. 1993).  
4.2 The in vivo m-RCT assay 
The key method applied in this thesis, the m-RCT assay, is designed to model the human 
arterial macrophage-originated RCT process. Due to technical limitations, studying 
cholesterol efflux in situ in the human vessel wall is not feasible. The m-RCT method uses 
macrophages administered at locations outside the vessel wall and, as such, relies on the 
assumption that the location (peritoneal cavity, skin) is a close enough surrogate of the 
situation within the vascular wall. However, several factors affecting cholesterol efflux in 
atherosclerotic plaques, such as hypoxia and pH, are not reflected in the model. The m-RCT 
method has also been criticized for the use of macrophage cell lines (such as J774A used in 
this thesis). Compared to native macrophages, immortalized cells are less efficient in 
effluxing cholesterol and as exogenous material they will evoke an immunological response. 
Endotoxemia and inflammation impair m-RCT by reducing cholesterol efflux from 
macrophages and by inhibiting biliary cholesterol excretion (McGillicuddy et al. 2009). 
Therefore, it is plausible that the injected macrophages evoked local inflammation in the 
peritoneal cavity, or induced the secretion of systemic immune mediators, which interfered 
with the long time-frame (24 or 48 h) m-RCT assays (McGillicuddy et al. 2009, Annema et al. 
2010).  
4.3 The stressor 
Restraint was chosen as a stressor based on its ability to produce a stable increase in 
corticosterone production during the exposure without producing pain to the animal. The 
use of only one type of stressor in all of the experiments facilitated the direct comparison of 
results across the studies. However, for the exploration of the atherogenic potential of 
stress, restraint may not be the optimal choice since social stressors have been proven 
more efficient (Bernberg et al. 2012). Furthermore, due to the relatively mild nature of 
restraint as a stressor, any stress derived from handling or background environmental 
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factors (Balcombe et al. 2004) may have masked differences between control and stressed 
mice. A prime example of such background stressor was the housing of mice on grid-
bottom cages due to collection of feces during the m-RCT assays. 
Several stress studies have been conducted in animals by using repeated or continuous 
administration of glucocorticoids. We did not want to extend our studies in this setting 
because the MR and GR binding affinities of synthetic glucocorticoids differ from those of 
natural stress hormones (de Kloet et al. 1975). Moreover, their ability to penetrate tissues 
may vary: for example, dexamethasone does not effectively cross the blood-brain barrier 
because it is a substrate for the efflux transporter multidrug resistance P-glycoprotein 
(Meijer et al. 1998). Due to such differences, the strength of the negative feedback exerted 
towards pituitary CRH excretion may also differ among synthetic and naturally occurring 
glucocorticoids. 
Our studies were conducted solely in female mice. In a small pilot study, only a weak trend 
towards an elevation in the fecal excretion of macrophage cholesterol during the m-RCT 
assay was observed between acutely stressed and control male mice (unpublished data, not 
shown). The rise in serum corticosterone in restrained male mice was smaller than in 
restrained female mice (+130% in acutely stressed male mice vs. +400% in acutely stressed 
female mice) supporting the concept that the female gender might be more responsive to 
certain types of stress. In addition to hormonal status, several other factors such as 
different basal levels of urocortin 1 might affect the gender-specific regulation of the HPA 
axis (Goel and Bale 2010, Derks et al. 2010).  
VI Summary and conclusions 
Transport of cholesterol via HDL from macrophages to feces provides protection against 
atherosclerosis progression. The multi-step m-RCT pathway can be regulated by a wide 
range of genetic and environmental factors. The effects of two such factors, mast cell 
activation and psychological stress, were studied in this thesis. Figure 7 summarizes the key 
findings of the conducted in vivo experiments. 
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Figure 7. Modulation of the m-RCT pathway in mice treated with a mast cell-activating compound 
48/80 or exposed to psychological stress. The m-RCT pathway involves the net movement of 
cholesterol (CHOL) from peripheral tissues, including the cholesterol-loaded macrophage foam cell on 
vascular wall (1), to the liver (2) and intestine (3). The pathway was modulated by local mast cell 
activation, which reduced cholesterol efflux from macrophage foam cells, and by psychological stress 
which, via corticosterone (CORT), modulated the final steps of the pathway in the liver and intestine. 
“Acute” stress (i.e. exposure to a single 3-hour stress session) induced a CORT-mediated increase in 
the intestinal gene transcription of an energy metabolism-regulating nuclear factor PPARα, which 
hampered the expression of the key intestinal cholesterol-absorbing transporter NPC1L1 and 
consequently, intestinal cholesterol absorption. The hepatic uptake of circulating HDL-cholesterol and 
the expression of the cholesterol receptor SR-BI was also modestly increased in acutely stressed mice. 
When stress was repeated once or twice a day for 5 days (here “chronic” exposure), both NPC1L1 and 
the intestinal cholesterol efflux pump ABCG5/8 were downregulated at the mRNA level, and 
cholesterol absorption remained unchanged. The chronic stress-induced stimulation of colonic transit, 
which likely occurred via corticotrophin releasing hormone (CRH), reduced intestinal absorption of 
bile acids (BA). This was reflected by decreased BA concentration in the gallbladder bile and reduced 
expression of the bile acid sensor Fxr in the liver of the stressed mice. Eventually, the reduced 
intestinal bile acid absorption translated into stimulated m-RCT. 
 
By utilizing a mouse model, we showed that pharmacological activation of peritoneal mast 
cells promoted local chymotryptic activity in a degree that was able to locally deplete preβ-
HDL, a minor HDL population that plays a predominant role as a cholesterol acceptor from 
foam cells (Figure 7). Consequently, the stimulatory effect of exogenous apoA-I on m-RCT 
was completely blocked. This finding is compatible with the in vivo observations according 
 65 
to which inhibition of intimal mast cell activation within an atherosclerotic lesion hinders 
lesion development (Bot et al. 2011). Mast cells are likely involved in the generation of 
foam cells also in the human atherosclerotic lesions.  
In addition to pharmacological agents, physiological factors such as psychological stress 
may trigger the activation of mast cells (Spanos et al. 1997, Huang et al. 2002). Stress itself 
is also an independent, potential factor affecting atherosclerosis and cholesterol transport. 
The various effects of the stress axes, the HPA-axis and the SNS, intertwine into a complex 
network of events, the most fundamental result of which are a fast reprogramming of 
energy metabolism and, after the acute challenge is managed, adjustment of the immune 
system to protect the potentially damaged body (Sapolsky et al. 2000). Human 
epidemiological data associate psychological stress and increased glucocorticoid secretion 
to cardiovascular disease (Rosengren et al. 2004) although previous studies in animals have 
yielded somewhat contradicting results (McCabe et al. 2002, Bernberg et al. 2009).  
In our studies, acute stress exposure in mice induced a modest upregulation of the hepatic 
HDL-cholesterol receptor SR-BI and accordingly, an increase in the hepatic uptake of 
circulating HDL-cholesterol (Figure 7). In addition, both acute and repeated stress exposure 
during 5-7 days promoted m-RCT by inducing fecal excretion of macrophage-derived 
cholesterol and bile acids made thereof, respectively (Figure 7). Whereas a molecular 
pathway behind the increased m-RCT in acutely stressed mice was identified, despite 
extensive studies, no transporter-mediated mechanism was found that could explain the 
observed reduction in bile acid absorption in repeatedly stressed mice. This leaves 
physiological, transient inductions of large intestinal transit as the most likely explanation 
for the stimulation of m-RCT under subchronic stress.  
Altogether, the changes evoked by acute and repeated restraint stress in this study 
promoted m-RCT in mice. The findings could in part explain why some studies, especially 
those applying chronic physical stressors in animal models of atherosclerosis, have not 
shown any correlation between stress and atherosclerosis development (Bernberg et al. 
2009).  
Our studies also demonstrate that the rate of the macrophage-specific RCT can be 
regulated both at the initial step (efflux) and at the final step that occurs in the gut 
(cholesterol absorption). The latter mechanism is non-specific regarding m-RCT because it 
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affects all cholesterol molecules in the intestine, independent of their source. It has been 
proposed, based on mouse studies, that no single step in the net transfer of cholesterol 
from peripheral tissues into feces is rate-limiting; that is, it is necessary to stimulate 
multiple steps of the RCT pathway if cholesterol flux through the entire pathway is to be 
significantly increased (Alam et al. 2001). In Study II, acute psychological stress was 
established as a factor capable of stimulating cholesterol uptake into the liver and excretion 
of cholesterol into the feces. Examples of other factors that, similar to acute stress, may 
alter several components of the m-RCT pathway include inflammation (McGillicuddy et al. 
2009, Annema et al. 2010), dietary modifications (WD), exercise (Meissner et al. 2011), and 
various drugs that affect the function of nuclear factors that regulate cholesterol and bile 
acid homeostasis (Table 2). More such information about the physiological and 
pharmacological regulation of RCT is needed because modulation of the m-RCT pathway is a 
promising approach to regress atherosclerosis and to design novel prevention strategies for 
cardiovascular diseases. 
The clinical significance of most of our findings is yet to be established. The methodologies 
to simultaneously quantify several components of RCT in humans have just begun to 
emerge (Turner et al. 2012, Davidson et al. 2013). The various actions of stress and mast 
cells in the local environment of the vascular wall, combined with the ability of stress to 
influence other cardiovascular risk factors such as hypertension, make it difficult to 
envisage their overall effects on cardiovascular health. The methodologies to quantify m-
RCT in humans need to be developed further to uncover the effects of the various 
atherosclerosis risk factors on m-RCT and finally, to the initiation and progression of 
cardiovascular diseases.  
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